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ABSTRACT 
 
S. aureus is an opportunistic pathogen with an extensive host range, and 
is the etiologic agent of a wide variety of human diseases, with the ability 
to promote disease in most human tissues. A repertoire of virulence 
factors expressed during colonization and infection all contribute to the 
success of S. aureus as a pathogen. S. aureus is not classically 
considered as an intracellular pathogen, yet accumulating scientific 
evidence has demonstrated that this organism has intracellular survival 
strategies, with the ability to become internalised by, and persist within, a 
wide range of non-professional eukaryotic phagocytes. This phenomenon 
has been shown to be linked to the expression of genes under the 
regulation of the S. aureus quorum sensing system, agr. Specifically, S. 
aureus has been shown to breach the host-membrane bound endosome 
within which it is situated upon internalisation, a process which has been 
hypothesised to rely upon a switch in gene expression due to the 
accumulation of the agr signalling peptide within the endosome. 
 
Many in vitro imaging modalities have been designed to investigate further 
the mechanisms behind S. aureus internalisation. However, in vivo 
systems such as bioluminescence and fluorescence reporter genes are 
limited by various factors including light extinction, restricting investigations 
to those using small animals. Additionally, as fundamentally two-
dimensional modalities, useful anatomical information is minimal in these 
imaging techniques. At present few imaging modalities exist which enable 
  
 
 
the non-invasive in vivo detection of bacterial reporter gene expression 
while offering detailed anatomical information. This study aimed to 
address the need to develop reporter systems for the non-invasive in vivo 
tracking systems for the monitoring of infectious disease processes, in the 
context of using such a technology to investigate further the genes 
involved in the process of S. aureus internalisation, and more specifically, 
endosomal escape. 
 
Although it is clear that agr regulated genes have a role in endosomal 
escape of internalised S. aureus, it is not fully clear which genes 
specifically are important. A number of haemolysin genes are under the 
control of the agr system, all of which have the ability to disrupt eukaryotic 
cell membranes. A β-haemolysin mutant was constructed in this study to 
use in conjunction with existing α-, δ- and γ-haemolysin mutants in in vitro 
internalisation assays. Initial experiments indicated a role for α-haemolysin 
in the endosomal escape of internalised S. aureus. The use of an in vivo 
reporter gene system would allow for further analysis of the role of 
haemolysins in endosomal escape, in addition to providing detailed 
anatomical information. 
 
MRI bacterioferritin (BFR) reporter genes with inducible or constitutive 
promoters, the bfr gene and the lux operon, were constructed and 
evaluated in S. aureus. The reporter gene was shown to be translated in 
vitro, with the expression of functional BFR which collected iron. However, 
ICP-MS data revealed relatively low levels of BFR. Pilot in vivo studies 
  
 
 
were carried out to confirm the potential of the reporter gene for studying 
specific aspects of staphylococcal disease. Experiments tracking 
bioluminescence in a mouse tumour model demonstrated expression of 
the MRI reporter genes, suggesting that bacterioferritin should be 
successfully synthesised in vivo. However, due to plasmid instability in 
vivo and the relatively low levels of iron present in S. aureus samples as 
determined by ICP-MS, the tumours in this study were not scanned by 
MRI. 
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RN6390 genome and the blue line represents the pTS1-Dest hlb 
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backbone. Primers in grey text would not yield product due to lack of an 
annealing site. 
 
FIGURE 4.20: Agarose gel electrophoresis showing PCR products from 
PCR of genomic DNA from S. aureus RN6390 and the S. aureus RN6390 
hlb mutant, and pTS1-Dest hlb plasmid DNA, using primers specific for 
regions outside of the hlb gene which were used to construct the pTS1-
Dest hlb plasmid and primers specific for the erm cassette. 
 
FIGURE 4.21: Cell Invasion Assay 
Bioluminescence as relative light units (RLU) divided by optical density 
(OD) of S. aureus RN6390 harbouring pSB2030 S. aureus RN6390 
harbouring pSB2035. For comparison, different scales are used to 
represent data relating to growth (left y axis) and agr expression (right y 
axis) to compensate for variations in promoter strength. Results represent 
the mean value of 6 data points for each reading. 
 
FIGURE 4.22: Cell Invasion Assay 
Fluorescence normalised for growth of S. aureus RN6390 and S. aureus 
RN6390 ∆hla, both harbouring pMK4 PxylA-gfp-term Results represent the 
mean value of 3 data points for each reading.  
 
FIGURE 5.1: Photos overlaid with luminescence images of mice 
inoculated with S. aureus harbouring pUNK1 PS10-dual-term. Images show 
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luminescence 1, 2 and 3 days post-inoculation. Order of mice does not 
remain the same for each picture. 
 
FIGURE 5.2: Photos overlaid with luminescence images of mice 
inoculated with S. aureus harbouring pUNK1 PS10-bfr-luxterm. Images 
show luminescence 2 and 3 days post-inoculation. Order of mice does not 
remain the same for each picture. 
 
FIGURE 5.3: Photos overlaid with luminescence images of mice 
inoculated with S. aureus harbouring pUNK1 P3-bfr-luxterm. Images show 
luminescence 1 day post-inoculation. 
 
FIGURE 5.4: Viable cell counts from the livers, spleens and tumours of 
one mouse from each test group. Mice were inoculated with S. aureus 
pUNK1 PS10-dual-term (1 on the graph), S. aureus pUNK1 PS10-bfr-luxterm 
(2 on the graph) or S. aureus pUNK1 P3-bfr-luxterm (3 on the graph).  
 
FIGURE 5.5: Confocal microscopy showing colonisation of a tumour 
removed from a mouse inoculated with S. aureus pUNK1 PS10-bfr-luxterm. 
Actin was stained red to visualise tumours and S. aureus was labelled 
using FITC (A2, B2, C2 and D2). Images were then overlaid (A1, B1, C1 
and D1). Labelled S. aureus can be seen with (A2) and without (B2) 
background correction. C1 shows the same tumour as in A1 and B1, but 
without anti-Protein A antibody. D1 shows a tumour from a mouse with no 
S. aureus inoculation.  
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FIGURE 6.1: Diagram showing a potential stem loop in the mRNA 
sequence of the intergenic region between the bfd and bfr genes. The red 
highlights the RBS of the bfr gene and the blue highlights the end of the 
bfd gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  1 
1.0: INTRODUCTION 
 
1.1: Non-Invasive in vivo Molecular Imaging 
 
The use of animal models to monitor microbial pathogenesis is 
fundamental to the investigation of host-pathogen interactions during 
disease processes. Conventional methods necessitated the euthanisation 
of experimental animals at various time points for analysis of colonisation 
sites and microbial quantities (Hutchens, M. and Luker, G.D., 2007). Our 
understanding of infectious diseases has been greatly facilitated by such 
methods, but more recently, a range of non-invasive in vivo molecular 
imaging techniques have been developed, which can be described as 
having a direct or indirect strategy. Direct imaging involves use of probe-
target interactions to analyse endogenous genes and molecules via 
interactions with target epitopes or enzymes. Indirect imaging strategies 
are much more complex. One example of indirect imaging that is 
becoming increasingly popular is reporter gene imaging. This typically 
involves a reporter gene, a reporter probe and imaging systems capable of 
visualising the probe (Blasberg, 2002; Serganova et al., 2006). 
 
Such novel non-invasive in vivo molecular imaging techniques can be 
used to achieve the temporal monitoring of both eukaryotic gene 
expression, and also microbial disease progression, offering functional 
information regarding microbial gene expression. Broadly speaking, these 
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techniques can be categorised as optical imaging, nuclear imaging and 
magnetic resonance imaging modalities (Serganova et al., 2006). 
 
1.1.1: Non-Invasive Optical in vivo Imaging 
Optical imaging uses bioluminescence and fluorescence to monitor 
molecular and biological processes. This can be achieved through the use 
of endogenous reporters, for example genetically modified target cells or 
recombinant bacteria transformed with bioluminescent or fluorescent 
reporter genes, or through use of exogenous probes which can target 
specific cell types (Hickson, 2009). This imaging technique is implemented 
widely in in vitro studies, including those analysing bacterial infection 
processes, due to its safety, low cost and ease of use relative to other 
imaging modalities (Leevy et al., 2007). However, optical imaging has also 
been implemented to some extent in in vivo investigations. 
 
1.1.1.1: Fluorescence 
Fluorescence is created when emission of a photon is triggered by the 
molecular absorption of another photon at a shorter wavelength (Leevy et 
al., 2007). Fluorescence reporters have been successfully implemented in 
various in vivo studies, for example in the imaging of E. coli expressing 
green fluorescent protein (GFP) in the gastrointestinal tract of mice (Zhao 
et al., 2001). However, their use in vivo is limited for a number of reasons. 
Firstly, the light produced from fluorescent reporter genes is attenuated 
and scattered by surrounding tissues in vivo. This problem is further 
exacerbated by the endogenous autofluorescence of tissues creating 
  3 
significant background emission. However, the latter issue has been 
somewhat improved by the development of a variety of GFP mutants 
which emit photons at all colours in the visible spectrum (Leevy et al., 
2007). Of particular importance are red fluorescent proteins (RFP), which 
avoid much of the autofluorescence problems, and also penetrate tissues 
more effectively, making them useful in the imaging of larger animals. 
Recently, this characteristic of RFP has been exploited in the development 
of infrared fluorescent proteins (Shu et al., 2009). 
 
1.1.1.2: Bioluminescence 
Bioluminescence is created by the generation of visible light by the 
enzymatic action of luciferases causing oxidation of luciferin substrates 
(Serganova et al., 2006). In this way, light intensity can be directly related 
to the amount of luciferase, and subsequently, the gene of interest within 
the reporter gene system, being expressed. Unlike fluorescence, 
background tissue emission of light is very low, minimising any effects on 
the specificity and sensitivity of this technique. Due to such advantages, 
bioluminescence has been implemented in a variety of studies. Using a 
novel modified operon, Francis et al. (2000) were able to tag 
Staphylococcus aureus strains with bioluminescence reporter genes, 
allowing the assessment of antibiotic efficacy in vivo. Bioluminescence 
reporter systems have also been employed to determine the colonization 
dynamics of Citrobacter rodentium in mice (Wiles et al., 2004) and the 
replication of Listeria monocytogenes within murine gall bladders (Hardy et 
al., 2004). 
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However, despite the benefits of low cost, high throughput and the 
functional data that this optical imaging modality facilitates, various 
limitations exist which minimise the scope of its use. As with fluorescence, 
light extinction is unavoidable, with bioluminescence being decreased by 
as much as 10 fold per cm depth, due to penetration of overlying tissues, 
organ pigmentation, fur and scattering of light, thus limiting the technique 
to use in small animals. Importantly, as a fundamentally two-dimensional 
modality, useful anatomical information is minimal, with difficulties 
separating light output from closely located anatomical locations, and 
resolution limitations. 
 
1.1.2: Non-Invasive Nuclear in vivo Imaging 
Various successful non-invasive nuclear in vivo imaging systems exist with 
the potential for use in bacterial disease tracking. Single photon emission 
computed tomography (SPECT) has been implemented in the imaging of 
bacterial infections in mice via detection of a radiolabelled thymidine 
kinase substrate (Bettegowda et al., 2005). Positron emission tomography 
(PET) is used extensively in the clinic as a non-invasive imaging modality, 
with much importance in the staging of cancer. This technology has been 
successfully used to image the endogenous expression of reporter genes 
thanks to the development of complimentary radiolabelled probes and 
micro-PET scanners for use with small animals (Blasberg, 2002; 
Herschman, 2003). However, despite the relatively high sensitivity of 
nuclear imaging methods, resolution limitations restrict the detail of the 
anatomical information yielded from such a technique, and so reduce its 
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suitability as a candidate for a bacterial tracking imaging modality 
(Blasberg, 2002; Ray et al., 2004; Cohen et al., 2007). 
 
1.1.3: Non-Invasive Magnetic Resonance in vivo Imaging 
 
1.1.3.1: Magnetic Resonance Imaging 
The following information was assembled with reference to an online MRI 
tutorial package (www.mri-tutorial.com). 
 
Magnetic resonance imaging (MRI) is an imaging modality that measures 
the response of hydrogen molecules to a perturbation in a magnetic field. 
The body is composed largely of water molecules, each of which contains 
two hydrogen atoms and one oxygen atom. All nuclei that are electrically 
charged demonstrate a phenomenon called spin, in that they spin around 
their axis, and as such hydrogen nuclei demonstrate spin. This movement 
of the nuclei creates a magnetic field which can be measure like a 
mathematical vector, with an amplitude and a direction, and is referred to 
as the magnetic dipole moment (MDM). 
 
Simply speaking, an MRI scanner consists of a large magnet which 
creates a very stable and powerful magnetic field, the direction of which is 
termed the z axis. When a subject is inside an MRI scanner, the MDM of 
the hydrogen nuclei align in the direction of the magnetic field, along the z 
axis. The nuclei also begin to precess, whereby there is a change in the 
direction of the axis around which the spin is occurring. Once the subject 
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is inside the MRI scanner, a radiofrequency electromagnetic pulse (RF 
pulse) is applied perpendicular to the z axis. This causes the MDM of the 
nuclei to ‘tip’ in the direction of the x-y plane, altering their alignment 
relative to the z axis (Figure 1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1.1: Diagram adapted from www.mri-tutorial.com depicting the z axis, x-y plane 
and direction of tip of MDM upon application of the RF pulse. 
 
 
This ‘tipping’ generated by the RF pulse increases the energy state of the 
nuclei. As the MDM of the nuclei return to their original orientation, this 
energy is released. This process is termed relaxation, the rate of which is 
the parameter which is measured in MRI. 
 
x
y
z
MDM
RF pulse
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Relaxation rates can be measured as either T1 or T2 relaxation rates. 
Before the RF pulse is applied, the MDM amplitude is maximal in the z 
axis, whereas after the RF pulse has been applied, it is maximal in the x-y 
plane, due to ‘tipping’. During relaxation, therefore, two parameters can be 
measured; the re-growth of the amplitude along the z axis, or the T1 
relaxation rate, and the decay of amplitude in the x-y plane, or the T2 
relaxation rate. Nuclei within different tissues have different T1 and T2 
relaxation rates, providing the contrast on MR images which allows for the 
detailed anatomical information yielded from this imaging technique. 
 
1.1.3.2: Contrast 
As described above, MRI contrast is created due to differing relaxation 
rates within different body tissues causing varying signal strengths to be 
detected. These varying signal strengths are due to the fact that at any 
given moment after an RF pulse has been applied, nuclei within different 
tissues are at different stages of relaxation, with varying levels of MDM 
amplitude in the z axis and x-y plane. 
 
To achieve maximal contrast between different tissues, the RF pulse 
sequence can be altered to allow one of these contrast mechanisms to be 
emphasized. T1 weighted signals are achieved when differences between 
MDM amplitudes in the z axis are maximised, whereas T2 weighted 
signals are achieved when differences between MDM amplitudes in the x-
y plane are maximised. To augment contrast between different tissues 
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further, contrast agents, typically chosen for their magnetic properties, can 
be administered. 
 
1.1.3.3: Magnetic Resonance Imaging as a Tool for Non-Invasive in 
vivo Imaging 
MRI is widely used as a clinical diagnostic tool due to its non-invasive 
nature and high quality three-dimensional spatial resolution, generating 
detailed anatomical information. These factors have made MRI an exciting 
prospect in the non-invasive imaging of in vivo gene expression, through 
the use of MRI reporter genes that can modulate MRI contrast. This has 
been achieved in a number of ways using various MRI gene expression 
strategies. 
 
Firstly, the use of metal-complexed MRI agents which are chemically 
modified by the enzymatic activity of beta-galactosidase has been 
documented (Louie et al., 2000). The need for exogenous administration 
of the contrast material, however, creates issues with barriers to delivery 
and clearance of the agent (Cohen et al., 2005). More recently, 
endogenous reporters have been developed to overcome this problem, 
including chemical-exchange saturation transfer (CEST) agents. Nuclei 
can maintain their magnetic orientation through chemical reactions. If RF 
radiation was applied to an agent proton, it would raise to a higher energy 
state, which causes the nuclei to convert to a different chemical state. This 
energy is then transferred to water by the exchange of protons, thus 
affecting the amplitude of the MR signal (Ward et al., 2000). The MRI 
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contrast achieved in this case can be switched on and off (Gilad et al., 
2007). A recent advance describes the use of naturally occurring proteins 
found in magnetotactic bacteria. Specifically, the use of magA, a gene 
involved in iron sequestration within magnetotatic bacteria, as an MRI 
reporter has been shown to achieve MRI contrast due to the in vivo 
synthesis of magnetic iron-oxide nanoparticles (Zurkiya et al., 2008). 
These so called magnetosome proteins affect the MRI signal in a similar 
way to superparamagnetic iron-oxide nanoparticles (SPIONs). SPIONs are 
particles of iron oxide with superparamagnetic properties, causing them to 
acquire large magnetic moments when placed in an external magnetic 
field. However, the relatively large size of these particles creates issues 
with fast clearance (Ma et al., 2006). Additionally, the need for delivery of 
the contrast agent creates further complications. Finally, proteins involved 
in iron homeostasis have also been used, for example, ferritins, which are 
described in detail in the next section. 
 
These recent advances in the use of MRI in gene expression analysis 
have made it an exciting candidate for the development of a technology 
that enables the non-invasive in vivo detection of bacterial reporter gene 
expression while offering detailed anatomical information. Few imaging 
modalities exist which can offer such prospects. As such, bacterial MRI 
reporter genes would be a valuable tool in the future discovery of key 
aspects of microbial pathogenesis. Of further importance regarding the 
development of such a reporter gene system is the prospect of a reduction 
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in the number of experimental animals used in studies due to the potential 
for the temporal analysis of the same individual subject (Lyons, 2005). 
 
 
1.2: Bacterioferritin as an MRI Reporter 
 
1.2.1: Ferritins 
Ferritins comprise a superfamily of ubiquitous iron-storage proteins which 
are highly conserved throughout most organisms including animals, plants 
and bacteria (Andrews et al., 1992). The role of ferritins is the storage of 
iron in its non-toxic form, Fe3+, which is oxidised from Fe2+ at ferroxidase 
centres within the ferritin molecule. They are also involved in protection 
from free radical synthesis by sequestering iron within a central cavity 
(Harrison et al., 1996). 
 
Ferritins synthesised by different organisms share a similar structure, 
forming endogenous nanoparticles assembled from a 24 protein subunit 
shell that encloses an iron-oxide core capable of storing up to 4500 iron 
atoms in the form of crystalline ferrihydrite (Carrondo, 2003). Three types 
of ferritin have been discovered in bacteria, including the haem containing 
bacterioferritins (BFR), for example BFR from Escherichia coli. The haem 
within bacterioferritins is situated between pairs of the 24 monomers which 
associate as dimers (Carrondo, 2003). Two haem-free ferritins also exist; 
an archetypal ferritin, for example ftn, and a structurally different, 
dodecameric, Dps-like ferritin, for example that of Listeria innocua (Ilari et 
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al., 2000; Chiancone et al., 2004). S. aureus has various genes involved in 
the global regulation of intracellular iron concentrations, including those 
that encode for the Fur, PerR and Zur proteins. In addition, S. aureus also 
has genes which encode a number of iron storage proteins; ftnA which 
encodes for a ferritin, Ftn, and mrgA which encodes for a ferritin-like Dps 
homologue, MrgA (Horsburgh et al., 2001). 
 
1.2.2: The use of Ferritins as MRI Reporters in vivo 
The ferrihydrite core of ferritins confers superparamagnetic properties 
which affect the T1 and T2 relaxation rates of water (Vymazal et al., 1998). 
This results in the darkening of T2-weighted MRI causing contrast that is 
easily imaged (Gossuin et al., 2004). Consequently, ferritins are ideal 
candidates for the development of endogenous MRI reporters, eliminating 
the need for delivery of the contrast agent, and have been used as such in 
various studies employing human ferritins as MRI reporters in eukaryotic 
cells. Genove et al. (2005) demonstrated imaging of virus-transduced 
mouse neurons and glia in vivo in a time-lapse fashion over several 
weeks. Imaging of gene expression in C6 glioma tumours and transgenic 
mice has also been achieved (Cohen et al., 2005; Cohen et al., 2007). 
 
The use of such MRI reporter genes that can modulate MRI contrast are of 
great scientific value in the development of a non-invasive in vivo tracking 
system for microbial disease, as the additional anatomical information 
yielded by MRI in conjunction with the functional data related to gene 
expression would confer numerous advantages to this imaging modality in 
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the monitoring of infectious disease processes. Recently, this has been 
achieved by use of an E. coli bacterioferritin reporter system which 
allowed the imaging of tumour colonisation by E. coli. This tumour 
targeting behaviour demonstrates not only an exciting use for MRI 
reporters in the therapeutic monitoring of cancer treatments but also an 
ideal platform upon which to develop the use of MRI reporters in bacterial 
disease processes (Hill et al., manuscript in preparation). 
 
 
1.3: Staphylococcus aureus 
 
1.3.1: Background 
Staphylococcus aureus, of the Micrococcaceae family, is a spherical, 
Gram-positive bacterium which grows in grape-like clusters. Species of the 
genus Staphylococcus are ubiquitous commensals of humans, and 
furthermore, S. aureus is found naturally inhabiting the skin and mucous 
membranes of a high proportion of healthy humans. In fact, approximately 
20% of the population is estimated to be persistently colonized with S. 
aureus, and 60% of the population are intermittent carriers (Kluytmans et 
al., 1997). 
 
S. aureus is an opportunistic pathogen with an extensive host range, and 
is the etiologic agent of a wide variety of human diseases, with the ability 
to promote disease in most human tissues. A repertoire of virulence 
factors expressed during colonization and infection, including cell wall 
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components, toxins and enzymes, all contribute to the success of S. 
aureus as a pathogen. Infections associated with S. aureus include 
superficial skin infections and more serious diseases such as toxic shock 
syndrome and endocarditis. It is also often associated with long-term and 
persistent infections, frequently recurring after seemingly successful 
treatment (Alexander and Hudson, 2001). 
 
The threat posed by this persistent organism is further augmented by its 
ability to develop antimicrobial resistance. The prevalence of antibiotic 
resistant strains of S. aureus has increased with the introduction of novel 
therapies, resulting in the development of methicillin-resistant 
Staphylococcus aureus (MRSA). Methicillin was introduced in 1961 in an 
attempt to control strains of S. aureus already possessing genes encoding 
resistance to many β-lactam antibiotics (Schito, 2006). Nonetheless, 
resistance to methicillin was documented soon after its introduction 
(Hiramatsu et al., 2001). This resistance results from the action of an 
acquired penicillin-binding protein, PBP2a, which is encoded by a gene of 
nonstaphylococcal origin, the mecA gene (de Jonge and Tomasz, 1993; 
Berger-Bachi and Rohrer, 2002). 
 
A major concern regarding MRSA is the discovery of its involvement in a 
number of infections in non-healthcare settings (Schito, 2006). Such 
infections are referred to as community-acquired (CA) MRSA infections, 
which occur in healthy community-dwelling individuals with no established 
risk factors for MRSA acquisition (Maltezou and Giamarellou, 2006). 
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The current line of therapy relied upon for the treatment of MRSA is the 
use of glycopeptides, commonly vancomycin. However, fully vancomycin-
resistant S. aureus (VRSA) strains have now been discovered due to 
acquisition of a foreign vanA gene (Courvalin, 2006; Schito, 2006). 
 
1.3.2: Virulence 
S. aureus strains have a remarkably wide range of virulence factors which 
have been usefully categorised by Franklin and Lowy (1998), and their 
variety reflects the significance of S. aureus as an important pathogen in 
humans. Firstly, the peptidoglycan cell wall its self has endotoxin like 
activity, stimulating the release of a range of host inflammatory mediators. 
 
An array of surface proteins contributes to S. aureus pathogenicity via 
various mechanisms. Some proteins function as adhesins, facilitating 
bacterial adhesion to endothelial cells. Many of these proteins are able to 
bind to components of the extracellular matrix facilitating their colonisation 
in host tissue, for example the fibrinonectin binding proteins, clumping 
factors, collagen binding proteins, elastin binding proteins and protein A 
(Hauck and Ohlsen, 2006). In addition to binding molecules in the 
extracellular matrix, protein A is able to bind the Fc region of human 
immunoglobulin proteins conferring antiphagocytic effects.  
 
S. aureus also produce toxins with differing actions such as haemolysins, 
exfoliative toxins, pyrotoxigenic superantigens, Panton-Valentine 
leukocidin and enterotoxins, some of which are known to be responsible 
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for the symptoms of specific diseases within humans. Of recent concern is 
the emergence of highly virulent CA-MRSA and MSSA strains which 
express the Panton-Valentine leukocidin, an enzyme that creates pores in 
the cell membrane of leukocytes (Shallcross et al., 2009). 
 
In order to aid infection spread, S. aureus produces various enzymes such 
as proteases, hyaluronidases and lipases, which allow breakthrough into 
adjacent tissues areas to facilitate spread of infection. Other important 
enzymes include those responsible for antimicrobial resistance, as 
discussed previously. 
 
Finally, S. aureus possess various systems allowing them to exploit the 
host environment for their own survival. One such example is the iron-
responsive surface determinant (Isd) system which enables the uptake of 
iron in the form of haem-iron, from which the iron can then be liberated 
(Grigg et al., 2010). 
 
1.3.3: Quorum Sensing and Virulence Gene Regulation 
Apart from the toxins responsible for directly causing disease, such as α-
haemolysin or toxic shock syndrome toxin, no S. aureus virulence factor 
has been shown to have the capability of causing disease on its own 
(Fournier and Philpott, 2005). To establish infection, therefore, 
coordination of the expression of several virulence genes must take place. 
These virulence factors, along with other extracellular proteins involved in 
enabling adaptation to the environment, are the accessory proteins, and 
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the regulation of their expression is achieved primarily via two 
interconnected modes of regulation; response to cell density and response 
to external stimuli (Novick and Jiang, 2003).  
 
1.3.3.1: Response to Cell Density 
It has been suggested that during early growth, S. aureus surface protein 
genes are expressed at high levels, due to their roles in facilitating 
attachment to host cells and protecting bacterial cells from the host 
immune response. Later on in infection, a transition point occurs and 
exoprotein genes are expressed whilst surface protein expression is 
downregulated (Shompole et al., 2003). This switch in gene expression 
allows the bacteria to colonize the host and reach sufficient population 
densities before the production of virulence factors, thus increasing the 
chances of establishing a successful infection. In S. aureus this switch in 
gene expression is known to be regulated by quorum sensing, a cell 
density dependent gene expression regulatory system in bacteria (Peng et 
al., 1988). Quorum sensing regulated expression of virulence factor genes 
is thought to give bacteria a selective advantage over host defences, and 
so often plays an important role in the pathogenesis of the bacterium, as is 
the case in S. aureus (Smith and Iglewski, 2003). 
 
The best-studied two-component signal transduction system in S. aureus 
is the accessory gene regulator (agr) quorum sensing system. Various 
studies involving animal models, using S. aureus agr mutants, have shown 
that virulence of S. aureus is reduced when quorum sensing is impaired, 
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proving its role in the pathogenesis of S. aureus in some diseases 
(Abdelnour et al., 1993; Gillaspy et al., 1995). 
 
1.3.3.2: Response to External Stimuli 
In addition to quorum sensing, a variety of other virulence gene regulation 
systems have been discovered in S. aureus. Other two-component signal 
transduction systems in addition to agr play a large role in allowing a 
change in virulence gene expression in response to environmental stimuli, 
and include sae, srr and arl. S. aureus also possesses an alternative 
sigma factor σB which is activated by environmental stress and energy 
depletion. Finally, various transcription factors control transcription of 
various extracellular proteins, and include the SarA homologues, SarS, 
SarT and Rot (Novick, 2003). 
 
1.3.4: S. aureus Haemolysins 
Some of the proteins regulated by the agr quorum sensing system belong 
to the S. aureus haemolysin group of toxins. S. aureus produces four 
haemolysins: α-, β-, γ- and δ-haemolysin. 
 
α-haemolysin is a self-assembling, channel-forming exotoxin with a 
molecular weight of 33kDa produced by many S. aureus strains. It is toxic 
to many mammalian cells, and is characterised by its ability to lyse 
erythrocytes, being predominantly active against rabbit erythrocytes 
(Dinges et al., 2000). α-haemolysin is secreted as a water-soluble 
monomer which binds with host cell membranes and consequently 
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penetrates the lipid bilayer. The monomer then oligomerises to form a 
membrane-inserted cylindrical heptamer with a 1nm to 2nm pore capable 
of lysing the eukaryotic cell (Bhakdi and Tranum-Jensen, 1991). This is 
due to the efflux of K+ and other small molecules, and the influx of Na+, 
Ca2+ and other small molecules, causing osmotic swelling of the 
erythrocyte and eventual lysis. α-haemolysin is encoded by the hla gene 
and is transcribed under control of the previously described agr system 
(Dinges et al., 2000). 
 
S. aureus β-haemolysin is highly haemolytic for sheep erythrocytes but not 
rabbit erythrocytes, and is designated the “hot-cold” haemolysin due to an 
enhancement in haemolytic activity by incubation below 10°C after 
treatment at 37°C. The hlb gene encodes a 330-amino-acid polypeptide 
with a predicted molecular weight of 39kDa. A 34 residue signal sequence 
is cleaved from this polypeptide upon secretion, giving the mature protein 
with a molecular weight of approximately 35kDa. Like α-haemolysin, β-
haemolysin is also up regulated after the exponential phase (Dinges et al., 
2000). 
 
γ-haemolysin is a bicomponent toxin composed of two separate 
polypeptides which act synergistically causing damage to neutrophils, 
macrophages and many varieties of mammalian erythrocytes (Taylor and 
Bernheimer, 1974; Dinges et al., 2000). Despite the structure of γ-
haemolysin, the hlg locus actually comprises three genes, hlgA, hlgB and 
hlgC, whereby it is postulated that hlgB and hlgC are cotranscribed and 
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hlgA is separately expressed (Cooney et al., 1993). Each of the three 
genes encodes a protein, HlgA, HlgB and HlgC, which, in their mature 
form, have molecular weights of 32kDa, 32.5kDa and 34kDa respectively 
(Dinges et al., 2000). HlgA has previously been called the γ1 component of 
the toxin, and HlgC, the γ2 component. These components share 70% 
residue identity, and approximately 30% identity with HlgB (Cooney et al., 
1993). Similar to Panton-Valentine leukocidin, γ-haemolysin is made up of 
an S and an F component (for slow- and fast-eluting proteins in an ion-
exchange column), and it is thought that it is the S subunit that is important 
for mediating an inflammatory response within the host, leading to 
suggestions that the S subunit is responsible for the initial binding to host 
cell membranes (Dinges et al., 2000).  
 
δ-haemolysin is a 26-amino-acid peptide capable of causing damage to 
erythrocytes and other mammalian cells, and is made by 97% of S. aureus 
strains. This toxin forms an α-helix with regions of hydrophobicity and 
hydrophilicity, leading to suggestions regarding mechanisms of action that 
δ-haemolysin acts as a surfactant to disrupt the cell membrane (Dinges et 
al., 2000). δ-haemolysin production is controlled by agr, and δ-haemolysin 
itself is coded for by RNAIII, which acts as mRNA for the hld gene (Janzon 
et al., 1989). 
 
1.3.5: S. aureus as an Intracellular Organism 
S. aureus is not classically considered as an intracellular pathogen, yet 
accumulating scientific evidence has demonstrated that this organism has 
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intracellular survival strategies, with the ability to become internalised by, 
and persist within, a wide range of non-professional eukaryotic 
phagocytes; in fact, studies show that S. aureus is ingested by human and 
mouse osteoblasts (Ellington et al., 1999; Jevon et al., 1999), human 
umbilical vein endothelial cells (Menzies and Kourteva, 1998), bovine 
mammary epithelial cells (Bayles et al., 1998; Qazi et al., 2001), chick 
fibroblasts (Alexander and Hudson, 2001) and human keratinocytes 
(Kintarak et al., 2004). Furthermore, internalisation of S. aureus in vivo into 
chick osteoblasts has been reported (Reilly et al., 2000). In some cases 
this internalization appears to be mediated by cell surface-localized 
proteins including fibronectin binding proteins (Lammersa et al., 1999; 
Ahmed et al., 2001). Extracellular proteins have also been implicated; 
Haggar et al. (2003) demonstrated a role for an extracellular protein, 
extracellular adherence protein (Eap), which can rebind to the surface of 
S. aureus whilst also binding a variety of plasma protein including 
fibronectin and fibrinogen. Eap was infact shown to play a role in S. 
aureus adhesion and ultimately internalisation into eukaryotic cells, with 
Eap deficient mutant strains being internalised to a lesser extent than the 
wild type. Moreover, exogenously added Eap enhanced internalisation, 
whilst anti-Eap antibodies prevented internalisation of various S. aureus 
strains. 
 
Staphylococci are renowned for their capability to cause persistent 
infections in both humans and animals. The mechanisms employed to 
achieve such long-term colonization remain unknown. Nonetheless, the 
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now widely reported phenomenon of S. aureus internalisation and 
intracellular survival has led to hypotheses regarding the role of this 
internalisation in chronic recurrent staphylococcal diseases and persistent 
infections, drawing similarities with the benefits that this mode of 
colonization has for classic facultative intracellular organisms. This theory 
is supported by evidence of an intracellular reservoir of S. aureus in the 
nasal mucosa of patients with recurrent S. aureus rhinosinusitis (Clement 
et al., 2005). 
 
 
1.4: MultiSite Gateway® Technology 
 
MultiSite Gateway® Technology allows the simultaneous cloning of 
multiple DNA fragments in a defined order and orientation through use of 
site-specific recombination. MultiSite Gateway® donor vectors have two 
specific att sites flanking a cassette containing the ccdB gene and a 
chloramphenicol resistance gene (Cm-ccdB cassette). The ccdB gene 
allows for negative selection due to the inhibition of growth of E. coli 
caused by the ccdB protein, and the chloramphenicol resistance gene 
allows for counterselection. Polymerase Chain Reaction (PCR) products 
with flanking att sites can be used in BP recombination reactions to 
generate entry clones, whereby the Cm-ccdB cassette in the MultiSite 
Gateway® donor vector is replaced by the PCR product. In a similar 
manner, three entry clones containing, for example, a promoter, a gene of 
interest and a terminator, respectively, can be used in an LR 
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recombination reaction with a MultiSite Gateway® destination vector also 
containing two specific att sites flanking the Cm-ccdB cassette, to 
simultaneously transfer the three DNA fragments into the destination 
vector. 
 
This technology is possible due to the specificity of the att sites; attB sites 
will recombine only with their cognate att sites, enabling the DNA 
fragments to be incorporated into a donor vector in a particular orientation, 
and subsequently into a destination vector in a specific order. To this end, 
different donor vectors are available with different att sites. This system is 
illustrated in Figure 1.2 and Figure 1.3. 
 
 
 
 
 
 
 
FIGURE 1.2: BP Recombination Reaction 
Recombination of an attB substrate, in this example an attB PCR product, with an attP 
substrate, in this example a donor vector with attP sites found on pDONR P4-P1R, to 
create an attL and attR containing entry clone for use in MultiSite Gateway® Three-
Fragment Vector Construction. The reaction is catalyzed by BP Clonase™ II enzyme mix, 
a mixture of the λ Integrase (Int) and E. coli Integration Host Factor (IHF) proteins 
(Invitrogen). 
 
 
+
BP ClonaseTM
Cm-ccdBattP4 attP1R
pDONR-5’ element
attB4 attB1
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FIGURE 1.3: LR Recombination Reaction 
Recombination of attL and attR containing entry clones with each other and an attR 
containing destination vector to create an attB containing expression clone. The reaction 
is catalyzed by LR Clonase™ II Plus enzyme mix, a mixture of the λ Int and Excisionase 
(Xis) proteins, and the E. coli IHF protein (Invitrogen). 
 
 
1.5: Aims and Objectives 
 
This aims of this study are based upon the need to develop reporter 
systems for the non-invasive in vivo tracking systems for the monitoring of 
infectious disease processes, in addition to the investigation of S. aureus 
haemolysin mutants both in vitro and through use of the developed 
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reporter system. To achieve these aims, the following objectives were 
formulated: 
 
1. To construct and evaluate in vitro an MRI bacterioferritin reporter gene 
for S. aureus. 
2. To evaluate the S. aureus MRI bacterioferritin reporter gene in vivo in 
an established mouse model. 
3. To construct a β-haemolysin mutant in S. aureus using Gateway® 
technology for the in vitro analysis of the involvement of agr regulated 
gene products in endosomal escape. 
4. To evaluate the S. aureus haemolysin mutants in conjunction with the 
MRI reporter in a specific disease model. 
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2.0: MATERIALS AND METHODS 
 
2.1: Bacterial Strains and Plasmids 
 
TABLE 2.1: Bacterial strains and plasmids used in this study. 
Organism/Plasmid Description Source or Reference 
Strain   
E. coli TOP10 E. coli cloning isolate, recA, endA 
genotype 
Invitrogen 
E. coli One Shot® ccdB 
Survival™ T1 Phage-
Resistant Cells 
Derivative of TOP10 strain, 
resistant to the ccdB gene 
product, tonA genotype to confer 
resistance to T1 and T5 phage  
Invitrogen 
S. aureus RN4220 Restriction deficient agr mutant, 
derivative of 8325-4 
Kreiswirth et al., 1983 
S. aureus RN6390 agr+ laboratory strain, derivative 
of 8325-4 
Peng et al., 1988 
S. aureus 8325-4 Wild-type strain, cured of 
prophages and plasmids 
Novick, 1967 
Plasmid   
pSB2030 PxylA-gfp3opt-luxABCDE inserted 
into pGC4 backbone, AmpR, CmR 
Qazi et al., 2001 
pSB2035 P3 amplified by PCR from S. 
aureus 8325-4, exchanged with 
PxylA from pSB2030, AmpR, CmR 
Qazi et al., 2001 
pSB3010 3 fragment expression cassette 
in pMK4, 
xylRPxylA:luxABCDE:rrnBT1T2 
Perehinec et al., 2007 
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pSB3016 3 fragment expression cassette 
in Gateway® destination vector 
pDEST-pTS1, 
PxylRA:intC:rrnBT1T2, AmpR, CmR 
 
Hill laboratory 
collection 
pDONR P4-P1R Gateway® entry vector, attP1R 
and attP4 sites to clone attB4 
and attB1 flanked PCR products, 
KmR, CmR, ccdB+ 
Invitrogen 
pDONR P221 Gateway® entry vector, attP1 
and attP2 sites to clone attB1 
and attB2 flanked PCR products, 
KmR, CmR, ccdB+ 
Invitrogen 
pDONR P2R-P3 Gateway® entry vector, attP2R 
and attP3 sites to clone attB2 
and attB3 flanked PCR products, 
KmR, CmR, ccdB+ 
Invitrogen 
pTS1-Dest +lac Gateway® destination vector,  
attR4 and attR3 sites for 
recombination with entry clones 
in a Multisite Gateway® LR 
reaction, contains temperature 
sensitive replicon, AmpR, CmR, 
ccdB+ 
Hill laboratory 
collection 
pDEST-pUNK1 pUNK1 containing attR4 and 
attR3 sites for recombination with 
entry clones in a Multisite 
Gateway® LR reaction, ErmR, 
CmR, ccdB+ 
Perehinec et al., 2007 
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pDONR P4-P1R::hlb up Gateway® entry vector, hlb 
upstream region amplified by 
PCR with incorporated att sites 
and cloned into pDONR P4-P1R 
by BP recombination reaction, 
KmR 
This study 
pDONR P221 ery PhiC Gateway® entry vector, attL1 
and attL2 sites flanking ErmR 
gene, KmR 
Hill laboratory 
collection 
pDONR P2R-P3::hlb 
down 
Gateway® entry vector, hlb 
downstream region amplified by 
PCR with incorporated att sites 
and cloned into pDONR P2R-P3 
by BP recombination reaction, 
KmR 
This study 
pTS1-Dest hlb pTS1-Dest +lac backbone with 
hlb upstream region, ErmR gene 
and hlb downstream region 
inserted via LR recombination 
reaction with entry clones 
pDONR P4-P1R::hlb up, pDONR 
P221 ery PhiC and pDONR P2R-
P3::hlb down, ErmR, CmR, AmpR 
This study 
pDONR P4-P1R Sa 
PS10 
Gateway® entry vector, S. 
aureus S10 promoter amplified 
by PCR with incorporated att 
sites and cloned into pDONR P4-
P1R by BP recombination 
reaction, KmR 
Hill laboratory 
collection 
   
  28 
pDONR P4-P1R Bs 
PS10 
Gateway® entry vector, B. 
subtilis S10 promoter amplified 
by PCR with incorporated att 
sites and cloned into pDONR P4-
P1R by BP recombination 
reaction, KmR 
Hill laboratory 
collection 
pDONR P4-P1R P3 Gateway® entry vector, S. 
aureus P3 promoter amplified by 
PCR with incorporated att sites 
and cloned into pDONR P4-P1R 
by BP recombination reaction, 
KmR 
Hill laboratory 
collection 
pDONR P4-P1R PahpC Gateway® entry vector, S. 
aureus PahpC promoter amplified 
by PCR with incorporated att 
sites and cloned into pDONR P4-
P1R by BP recombination 
reaction, KmR 
Hill laboratory 
collection 
pDONR P221 dual Gateway® entry vector, gfp-
luxABCDE amplified by PCR with 
incorporated att sites and cloned 
into pDONR P221 by BP 
recombination reaction, KmR 
Hill laboratory 
collection 
pDONR P221 bfd Gateway® entry vector, E. coli  
bfd gene amplified by PCR with 
incorporated att sites and cloned 
into pDONR P221 by BP 
recombination reaction, KmR 
This study 
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pDONR P221 bfr Gateway® entry vector, E. coli  
bfr gene amplified by PCR with 
incorporated att sites and cloned 
into pDONR P221 by BP 
recombination reaction, KmR 
Hill laboratory 
collection 
pDONR P221 bfd/bfr Gateway® entry vector, E. coli  
bfd and bfr gene amplified by 
PCR with incorporated att sites 
and cloned into pDONR P221 by 
BP recombination reaction, KmR 
This study 
pDONR P2R-P3 term Gateway® entry vector, rrnBT1T2 
amplified by PCR with 
incorporated att sites and cloned 
into pDONR P2R-P3 by BP 
recombination reaction, KmR 
Hill laboratory 
collection 
pDONR P2R-P3 
luxterm 
Gateway® entry vector, 
luxABCDE and rrnBT1T2 
amplified by PCR with 
incorporated att sites and cloned 
into pDONR P2R-P3 by BP 
recombination reaction, KmR 
This study 
pMK4 PxylA-gfp-term pMK4 backbone with PxylA, gfp 
and rrnBT1T2, AmpR, CmR 
Hill laboratory 
collection 
pUNK1 PxylA-dual-term pDEST-pUNK1 backbone with 
PxylA, gfp-luxABCDE and 
rrnBT1T2 inserted via LR 
recombination reaction with entry 
clones pDONR P4-P1R PxylA, 
pDONR P221 dual and pDONR 
P2R-P3 term, ErmR 
Hill laboratory 
collection 
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pUNK1 Sa PS10-dual-
term 
pDEST-pUNK1 backbone with S. 
aureus PS10, gfp-luxABCDE and 
rrnBT1T2 inserted via LR 
recombination reaction with entry 
clones pDONR P4-P1R Sa PS10, 
pDONR P221 dual and pDONR 
P2R-P3 term, ErmR 
This study 
pUNK1 Bs PS10-dual-
term 
pDEST-pUNK1 backbone with B. 
subtilis PS10, gfp-luxABCDE and 
rrnBT1T2 inserted via LR 
recombination reaction with entry 
clones pDONR P4-P1R Bs PS10, 
pDONR P221 dual and pDONR 
P2R-P3 term, ErmR 
This study 
pUNK1 PS10-bfd-luxterm pDEST-pUNK1 backbone with S. 
aureus PS10, E. coli bfd and 
luxABCDE-rrnBT1T2 inserted via 
LR recombination reaction with 
entry clones pDONR P4-P1R Sa 
PS10, pDONR P221 bfd and 
pDONR P2R-P3 luxterm, ErmR 
This study 
pUNK1 PS10-bfr-luxterm pDEST-pUNK1 backbone with S. 
aureus PS10, E. coli bfr and 
luxABCDE-rrnBT1T2 inserted via 
LR recombination reaction with 
entry clones pDONR P4-P1R Sa 
PS10, pDONR P221 bfr and 
pDONR P2R-P3 luxterm, ErmR 
This study 
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pUNK1 PS10-bfd/bfr-
luxterm 
pDEST-pUNK1 backbone with S. 
aureus PS10, E. coli bfd-bfr and 
luxABCDE-rrnBT1T2 inserted via 
LR recombination reaction with 
entry clones pDONR P4-P1R Sa 
PS10, pDONR P221 bfd/bfr and 
pDONR P2R-P3 luxterm, ErmR 
This study 
pUNK1 P3-bfr-luxterm pDEST-pUNK1 backbone with S. 
aureus P3, E. coli bfr and 
luxABCDE-rrnBT1T2 inserted via 
LR recombination reaction with 
entry clones pDONR P4-P1R P3, 
pDONR P221 bfr and pDONR 
P2R-P3 luxterm, ErmR 
This study 
pUNK1 P3-bfd/bfr-
luxterm 
pDEST-pUNK1 backbone with S. 
aureus P3, E. coli bfd-bfr and 
luxABCDE-rrnBT1T2 inserted via 
LR recombination reaction with 
entry clones pDONR P4-P1R P3, 
pDONR P221 bfd/bfr and 
pDONR P2R-P3 luxterm, ErmR 
This study 
 
pUNK1 PahpC-bfr-
luxterm 
pDEST-pUNK1 backbone with S. 
aureus PahpC, E. coli bfr and 
luxABCDE-rrnBT1T2 inserted via 
LR recombination reaction with 
entry clones pDONR P4-P1R 
PahpC, pDONR P221 bfr and 
pDONR P2R-P3 luxterm, ErmR 
This study 
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2.2: Chemical Reagents 
 
All of the general chemicals used in this study were obtained from Sigma 
Aldrich unless otherwise stated. 
 
 
2.3: Growth Media 
 
2.3.1: Luria-Bertani Medium 
Luria-Bertani (LB) broth was prepared using 10g tryptone (Oxoid), 5g 
yeast extract (Difco) and 5g sodium chloride made up to 1L with distilled 
water. The solution was then sterilised by autoclaving. 
 
LB agar was prepared as above with the addition of 1.5% (w/v) Number 1 
Bacteriological Agar (Oxoid). 
 
2.3.2: Brain Heart Infusion 
Brain Heart Infusion (BHI) broth (Oxoid) was prepared as described by the 
manufacturer. The solution was sterilised by autoclaving. 
 
BHI agar was prepared as above with the addition of 1.5% (w/v) Number 1 
Bacteriological Agar (Oxoid). 
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2.3.3: Tryptic Soy Broth 
Tryptic Soy Broth (TSB) (Oxoid) was prepared as described by the 
manufacturer. The solution was sterilised by autoclaving. 
 
TSB agar was prepared as above with the addition of 1.5% (w/v) Number 
1 Bacteriological Agar (Oxoid). 
 
2.3.4: LK Medium 
LK broth was prepared using 10g tryptone (Oxoid), 5g yeast extract (Difco) 
and 7g potassium chloride made up to 1L with distilled water. The solution 
was then sterilised by autoclaving. 
 
LK top agar was prepared as above with the addition of 0.75% (w/v) agar 
(Difco). LK-citrate agar was prepared as above with the addition of 1% 
(w/v) Number 1 Bacteriological Agar (Oxoid) and 0.05% (w/v) Na citrate.  
 
2.3.5: SMMP50 
SMMP50 medium was made up from 5.5 parts SMM buffer (1M sucrose, 
0.04M maleic acid, 0.04M magnesium chloride, pH 6.5), 4 parts 7% (w/v) 
Penassay broth and 0.5 parts 10% (w/v) bovine serum albumin. The SMM 
buffer and Penassay broth (Difco) were mixed and autoclaved and then 
the bovine serum albumin was filter sterilised and added to the sterile 
mixture. 
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2.4: Supplements 
 
Growth medium was supplemented with the following antibiotics, where 
appropriate, at the given concentrations, unless otherwise stated: 
 
Ampicillin (Amp):  100µg ml-1  
Chloramphenicol (Cm): 30µg ml-1 (Gram-negative organisms) 
5µg ml-1 (Gram-positive organisms) 
Kanamycin (Km):  50µg ml-1 
Erythromycin (Erm):  150µg ml-1 (Gram-negative organisms) 
5µg ml-1 (Gram-positive organisms) 
 
 
2.5: Growth Conditions 
 
Liquid cultures were grown aerobically in LB overnight at 37°C with gentle 
agitation at 200rpm unless otherwise stated. Agar plates were incubated 
statically overnight at 37°C unless otherwise stated. 
 
Growth of bacterial cultures in liquid medium was monitored by optical 
density at 600nm (OD600) using a Pharmacia Novaspec II 
Spectrophotometer. 
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2.6: DNA Manipulations 
 
2.6.1: Genomic DNA Purification 
Genomic DNA purification was carried out using DNeasy Blood and Tissue 
Kits (Qiagen) according to the manufacturer’s instructions. 
 
2.6.2: Plasmid Preparation 
Plasmid DNA preparation was carried out using QIAprep Spin Miniprep 
Kits (Qiagen) according to the manufacturer’s instructions. For S. aureus 
plasmid preparation, 5µl of lysostaphin (5mg ml-1 solution suspended in 
ddH2O) was added with the first buffer step (250µl Buffer P1) and 
incubated at 37°C for 30 minutes. 
 
2.6.3: Restriction Digests 
Cleavage of DNA with restriction enzymes (Promega) was performed 
according to ‘Current Protocols in Molecular Biology’ (Ausubel et al., 
2000). 
 
2.6.4: Construction of Entry Clones 
The PCR primers used in the construction of DNA fragments to be 
inserted into Gateway® entry clone vectors are described in Table 2.2 and 
were supplied by Sigma-Genosys Ltd. Gateway® BP Clonase™ Enzyme 
Mix (Invitrogen) was used according to the manufacturer's instructions. 
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2.6.5: LR Recombination Reactions 
Gateway® LR Clonase™ Enzyme Mix (invitrogen) was used according to 
the manufacturer's instructions. 
 
2.6.6: PCR Clean Up 
Purification of DNA fragments from PCR was achieved using a 
Zymoclean™ Gel DNA Recovery Kit (Zymo Research), according to the 
manufacturer's instructions. 
 
 
2.7: Agarose Gel Electrophoresis 
 
Agarose gels were prepared in 1 x TAE (40mM Tris Acetate, 2mM EDTA, 
pH8.5) at a concentration of 0.8% (w/v) agarose. Ethidium bromide was 
added to a final concentration of 10µg ml-1. Samples were loaded with 5µl 
Blue/Orange 6x loading Dye (Promega). Gels were run in 1 x TAE buffer 
at 80V and DNA was then visualised using an ultraviolet (UV) 
transilluminator. 
 
 
 
 
 
 
  37 
2.8: Polymerase Chain Reaction 
 
2.8.1: Primers 
 
TABLE 2.2: List of primers used in this study. Red text indicates Gateway® att sites. Blue 
text indicates incorporated restriction sites. 
 
Primer 
Name 
 
Nucleotide Sequence (5’-3’) Restriction/
att Sites 
hlb up F’ GGGG ACA ACT TTG TAT AGA AAA GTT GGT 
TTA AAC TCT ATC ATG CTT CAG TAC TG 
attB4 forward, 
PmeI 
hlb up R’ GGGG ACT GCT TTT TTG TAC AAA CTT GCA 
TTA TCA CTC CTT TTA TAT AGC 
attB1 reverse 
 
hlb down F’ GGGG ACA GCT TTC TTG TAC AAA GTG GTG 
CTC AAC TAA CTA ATA ACT TG 
attB2 forward 
 
hlb down R’ GGGG ACA ACT TTG TAT AAT AAA GTT GGT 
TTA AAC CTG AGA AGA ATC TTG ATG GTG 
attB3 reverse, 
PmeI 
hlb outside 
up F’ 
CCG ATA CCT CTA TCA TGC TTC N/A 
hlb outside 
down R’ 
GTT AGC ACT ATC GAC TAC TTT C N/A 
bfd F’ GGGG ACA AGT TTG TAC AAA AAA GCA GGC 
TAA GGA GGA ATA AAA AAT GTA CGT TTG 
TCT TTG TAA TGG TAT CAG C 
attB1 forward 
bfd R’ GGGG ACC ACT TTG TAC AAG AAA GCT GGG 
TTT ATG CGG ACT CCT TAA ACT CCG 
attB2 reverse 
bfr R’ GGGG ACC ACT TTG TAC AAG AAA GCT GGG 
TCT CAA CCT TCT TCG CGA ATC 
attB2 reverse 
pTS1 F’ GCT CAC TCA TTA GGC ACC N/A 
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pTS1 R’ GTA ACA TCT GAC CGA GAT T N/A 
ery F’ GCC ATA AAC TAT CAT ATC TTC N/A 
ery R’ GAT CCG AGC TTA TCG ATT TCG N/A 
luxA F’ GGGG ACA GCT TTC TTG TAC AAA AG GAG 
GAC TCT CTA TGA AAT TTG GAA AC 
attB2 forward 
 
term R’ GGGG ACA ACT TTG TAT AAT AAA GTT GTT 
TAA ACT GGC AGT TTA TGG CGG GC 
attB3 reverse, 
PmeI 
Sa S10 F’ 
 
GGGG ACA ACT TTG TAT AGA AAA GTT GTT 
TAA ACC GTT CTT ATG ACT AAT TAT ATA G 
attB4 forward, 
PmeI 
Bs S10 F’ 
 
GGGG ACA ACT TTG TAT AGA AAA GTT GTT 
TAA ACT CGA AAC AGT ATT ATC AAG AAC 
attB4 forward, 
PmeI 
 
 
 
 
2.8.2: General PCR Parameters 
All PCR reactions were performed in a Hybaid PCR Express Thermo 
(Hybaid, Ashford, UK) thermal cycler. Unless stated otherwise, reactions 
were performed in 50μl volumes with GoTaq DNA Polymerase. Briefly, on 
ice, 1μl of each primer (from 100μM stock), 100ng template, 1μl dNTP mix 
(to a final concentration of 10mM of each dNTP), 4μl MgCl (to a final 
concentration of 2mM), 10μl of 5 x buffer and 0.25μl GoTaq DNA 
Polymerase were mixed. The reaction was made up to a final volume of 
50μl with sterile distilled water. Reaction parameters were as follows: 
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       Initial Denaturation 95°C  2 minutes 
30 cycles of: 
       Denature  95°C  30 seconds 
       Anneal   48-65°C 30 seconds 
       Extend   72°C  1 minute/kb of PCR product 
       Final Extension  72°C  10 minutes 
 
2.8.3: AccuPrime™ Taq DNA Polymerase 
Some PCR reactions were performed using AccuPrime™ Taq DNA 
Polymerase (Invitrogen) due to the length of the expected PCR products. 
AccuPrime™ Taq DNA Polymerase is a high-fidelity DNA polymerase 
which is effective over a wide range of target sizes. Briefly, on ice, 1μl of 
each primer (from 10μM stock), 100ng genomic DNA template or 10ng 
plasmid DNA template, 5μl of 10 x AccuPrime buffer and 0.2μl 
AccuPrime™ Taq DNA Polymerase were mixed. The reaction was made 
up to a final volume of 50μl with sterile distilled water. Reaction 
parameters were as follows: 
 
       Initial Denaturation 94°C  2 minutes 
30 cycles of: 
       Denature  94°C  30 seconds 
       Anneal   48-65°C 30 seconds 
       Extend   68°C  1 minute/kb of PCR product 
       Final Extension  68°C  10 minutes 
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2.9: Transfer of Plasmid DNA into Bacterial Cells 
 
2.9.1: Dialysis of DNA, BP and LR Reactions 
DNA was dialysed against water using 0.025μm (13mm) dialysis filters 
(Millipore). A petri dish containing deionised water was used, and the filter 
was allowed to float on the surface with the shiny side facing upwards. 
10μl DNA was pipetted onto the filter and left to dialyse for 30 minutes. 
 
2.9.2: Preparation of Electrocompetent E. coli 
E. coli from an overnight culture grown aerobically at 37°C with gentle 
agitation at 200rpm, in 20ml LB broth was used to inoculate 1L sterile LB 
broth (1:100). This culture was grown as described above until an OD600 of 
0.5 was reached. The rest of the protocol was carried out on ice. Bacterial 
cells were harvested by centrifugation (4,000 x g, 4°C, 15 minutes) and 
then washed with 1L cold water. The cell suspension was then centrifuged 
as before, washed with 500ml cold water, and further centrifuged before 
washing with 20ml 10% glycerol. The suspension was centrifuged a final 
time, as before, and resuspended in 1ml 10% glycerol. 40μl aliquots were 
transferred to eppendorf tubes and frozen rapidly in liquid nitrogen before 
storage at -80°C. 
 
2.9.3: Electroporation of Plasmid DNA into E. coli 
10µl dialysed DNA was added to 40µl of electrocompetent cells, mixed on 
ice until the cells were fully thawed, and then transferred to a pre-chilled 
2mm gap gene pulser electroporation cuvette (Biorad). A single pulse of 
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2.5kV (200Ω) was delivered to the cuvette using a Biorad Gene Pulser. 
Immediately after the pulse 1ml LB broth was added, and the cell 
suspension was incubated statically at 37°C for 1 hour before plating onto 
the appropriate selective agar and incubation overnight at 37°C. 
 
2.9.4: Preparation of Electrocompetent S. aureus 
An overnight culture of S. aureus grown aerobically at 37°C with gentle 
agitation at 200rpm was diluted 1:50 into TSB, and grown aerobically at 
37°C until an OD600 of 0.3-0.8 was reached. Bacterial cells were harvested 
by centrifugation (8,000 x g, 10 minutes) and washed with an equal 
volume of 500mM sucrose. The cell suspension was then centrifuged as 
before, resuspended in 0.5 volume of 500mM sucrose and incubated on 
ice for 15-30 minutes. The suspension was centrifuged a final time, as 
before, and resuspended in 0.1 volume of 500mM sucrose. 40μl aliquots 
were transferred to eppendorf tubes and stored at -80°C. 
 
2.9.5: Electroporation of Plasmid DNA into S. aureus 
10µl dialysed DNA was added to 40µl of electrocompetent cells, mixed on 
ice until the cells were fully thawed, and then transferred to a pre-chilled 
2mm gap gene pulser electroporation cuvette (Biorad). A single pulse of 
2.5kV (100Ω) was delivered to the cuvette using a Biorad Gene Pulser. 
Immediately after the pulse 1ml SMMP50 medium was added, and the cell 
suspension was incubated statically at 37°C for 3 hours before plating 
onto the appropriate selective agar. 
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All plasmid DNA for electroporation into S. aureus RN6390 was first 
electroporated into S. aureus RN4220, a restriction negative strain 
capable of accepting E. coli DNA. Plasmid DNA was then isolated from S. 
aureus RN4220 as described in section 2.6.2 of Materials and Methods 
before electroporation into S. aureus RN6390. 
 
2.9.6: Phage Transduction 
The donor strain was grown overnight at 37°C aerobically in LB broth and 
used to inoculate a 10ml solution consisting of 5ml LB broth and 5ml 
phage buffer (1mM MgSO4, 4mM CaCl2, 50mM Tris-HCl pH7.8, 5.9g/L 
NaCl and 1g/L gelatin) until the solution appeared slightly turbid. 100µl 
phage 11 was then added, before 10 minutes incubation at room 
temperature. The solution was then incubated at 30°C shaking at 50rpm 
for approximately 4 hours, or until complete lysis had occurred and the 
solution appeared clear. The lysate was then filter sterilised. 
 
The recipient strain was grown overnight at 37°C aerobically in 20ml LK 
broth. The culture was then centrifuged (5,000 x g) for 10 minutes and 
resuspended in 1ml LK broth. 500µl of these cells were then mixed with 
1ml LK broth, 10mM CaCl2 and 500µl phage lysate, before static 
incubation at 37°C for 25 minutes, followed by aerobic incubation at 37°C 
for 15 minutes. 1ml ice cold 0.02M Na citrate was then added and 
incubated on ice for 5 minutes. The solution was then centrifuged as 
above and all supernatant was removed, before resuspension in 1ml ice 
cold 0.02M Na citrate. The solution was then incubated on ice for 2 hours 
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and plated onto LK-citrate plates containing the relevant selective 
antibiotic at 1/33 the concentration normally used. Plates were incubated 
at 37°C for 1.5 hours. Plates were then overlaid with 5ml LK top agar 
containing the relevant selective antibiotic at x6 the concentration normally 
used. Plates were then incubated at 37°C for 48 hours. 
  
 
2.10: Protein Visualisation using SDS-PAGE 
 
2.10.1: Preparation of Cell Lysates from E. coli 
10ml overnight culture at an OD600 of 0.5 were harvested by centrifugation 
and resuspended in 250μl 2 x SDS PAGE sample buffer (1g SDS, 10ml 
Glycerol, 10ml β-Mercapto Ethanol, 4ml 1M Tris-HCl pH 6.8, and a small 
amount of Bromophenol Blue, made up to total volume of 100ml with 
water). The cell suspension was boiled for 5 minutes and then centrifuged 
(13,000 x g, 5 minutes). 15μl of the suspension was loaded per lane of a 
15% (w/v) polyacrylamide gel. 
 
2.10.2: Preparation of Cell Lysates from S. aureus 
10ml overnight culture at an OD600 of 0.5 were harvested by centrifugation 
and resuspended in 500μl 80μg ml-1 lysostaphin in phosphate buffered 
saline (PBS). The cell suspension was incubated at 37°C for 30 minutes. 
250μl 2 x SDS PAGE sample buffer was then added and the cell 
suspension was boiled for 5 minutes and then centrifuged (13,000 x g, 5 
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minutes). 15μl of the suspension was loaded per lane of a mini acrylamide 
gel. 
 
2.10.3: SDS-PAGE Gel Electrophoresis 
Acrylamide gels were used for protein analysis by gel electrophoresis. 
15% Resolving Gel was made up with 5ml Acryl-bis (30% (w/v) 
acrylamide:0.8% bis), 1.25ml Resolving Gel Buffer, 100μl 10% (w/v) SDS, 
75μl 10% (w/v) AP, 3.2ml ddH2O and 5μl Temed. Approximately 2cm 
Stacking Gel (750μl 30% Acryl-bis, 1.5ml Stacking Gel Buffer, 60μl 10% 
SDS, 150μl 10% ammonium persulfate, 3ml ddH2O and 6μl Temed) was 
then poured on top of the resolving gel with a comb in place to create 
wells. 
 
Gels were run in running buffer (3.03g Tris, 1g SDS and 14.4g glycine in 
1L water) at 200V. 
 
Resolving Gel Buffer: 
3M Tris-HCl (pH 8.8), 36.3g Tris and 48ml 1M HCl mixed and made 
up to total volume of 100ml with water. 
 
Stacking Gel Buffer: 
0.5M Tris-HCl (pH 6.8), 6g Tris dissolved in 40ml ddH2O, titrated to 
pH 6.8 with 1M HCl and made up to total volume of 100ml with 
water. 
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2.10.4: Coomassie Staining 
Gels were stained with Coomassie Brilliant Blue solution (15ml Methanol, 
10ml Acetic Acid and 0.2g Coomassie Blue made up to total volume of 
100ml with water) overnight with gentle agitation before destaining with 
15ml Methanol and 10ml Acetic Acid made up to total volume of 100ml 
with water, for approximately 1 hour. Gels were then transferred to distilled 
water. 
 
 
2.11: Western Blotting 
 
2.11.1: Electrophoresis 
A gel/membrane sandwich was set up as shown in the diagram below: 
 
   Scotchbrite pad 
   3M paper 
   BioTrace NT 
   Gel 
   3M paper 
   Scotchbrite pad  
 
3M filter paper, blotting membrane (BioTrace NT) (PALL Life Sciences, 
USA) and BioRad Scotchbrite pads were all pre-soaked in blotting buffer 
(14.4g glycine, 3.03g Tris in 1L deionised H2O). The sandwich was gently 
compressed using a pipette on its side to remove any air bubbles, before 
being transferred to a holder and placed in the electrophoresis tank. The 
tank was filled with blotting buffer and the gel was then electrophoresed at 
a 140mA constant current for 1.5 hours. 
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2.11.2: Ponceau Staining 
The membrane was removed from the sandwich and stained with 
Ponceau S solution (Sigma) for 1 minute with gentle agitation. The 
membrane was then rinsed with ddH2O until bands were visible. 
 
2.11.3: Antibody Staining 
The membrane was blocked in 20ml 5% (w/v) skimmed milk in PBS for 15 
minutes at room temperature with gentle agitation before briefly rinsing 
three times with PBS in a tray. The membrane was then incubated in 20ml 
PBS with 5% (w/v) skimmed milk, 0.1% (v/v) Tween 20 and the primary 
antibody (polyclonal mouse-antiserum directed against bfr) at a 1:10 
dilution for 1.5 hours. Washing in PBS was then repeated for 5 minutes, 
three times, with gentle agitation. Incubation with the secondary antibody 
(rabbit anti-mouse, horseradish peroxidase conjugated) at a dilution of 
1:2000 was then carried out, as described above with the antibody, before 
washing as above. 
 
2.11.4: Enhanced Chemiluminescence (ECL) Developing 
3ml each of solutions A and B from an ECLTM Western Blotting Detection 
System kit (GE Healthcare) were mixed in a universal and pipetted onto 
the membrane in a tray. After 2-3 minutes of gentle agitation excess 
developer was drained off and the membrane was transferred to a clean 
acetate sheet and then covered with a second acetate sheet. Any air 
bubbles were gently removed by rubbing the top of the acetate sheet with 
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blue roll. The membrane was then exposed to ECL film with the protein 
side of the membrane towards the film. 
 
 
2.12: Bacterial Mutagenesis 
 
2.12.1: Construction of Knockout Mutants 
S. aureus harbouring the temperature sensitive pTS1 mutagenesis 
plasmid were grown overnight statically in LB supplemented with 5μg ml-1 
Cm and Erm at 30°C to facilitate recombination. Cultures were then diluted 
10 fold in LB and 100μl volumes of 10-4, 10-5 and 10-6 dilutions were plated 
onto LB agar supplemented with 5μg ml-1 Erm before incubation overnight 
at 42°C to promote plasmid loss. Any colonies were replica plated onto LB 
agar supplemented with 5μg ml-1 Cm and then onto LB agar 
supplemented with 5μg ml-1 Erm, before incubation overnight at 37°C. 
Genomic DNA purification of colonies which grew on Erm supplemented 
plates but not Cm supplemented plates was carried out and DNA was 
screened by PCR. 
 
2.12.2: Excision of the ErmR Gene 
The S. aureus RN6390 ∆hlb was transformed with the pTS1 intC 
expression vector, pSB3016, and grown statically at 30°C to early log 
phase. Xylose was then added at a final concentration of 1% (w/v), before 
further incubation aerobically at 30°C for 5 hours. Cultures were then 
diluted 10 fold in LB and 100μl volumes of 10-4, 10-5 and 10-6 dilutions 
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were plated onto non-selective LB agar before incubation overnight at 
42°C to promote loss of the temperature sensitive pSB3016 plasmid. Any 
colonies were replica plated onto LB agar alone, LB agar supplemented 
with 5μg ml-1 Cm and LB agar supplemented with 5μg ml-1 Erm in order to 
detect clones which had lost both the chromosomal erm gene and the IntC 
expression vector. 
 
 
2.13: Iron Quantification 
 
2.13.1: Iron Assay 
A QuantiChromTM Iron Assay Kit (DIFE-250) (Bioassay Systems) was 
used for quantification of iron concentrations in cell lysates. Standards 
were prepared as described by the manufacturer and mixed with 50µl 
overnight culture at an OD600 of 0.5. Reagents were added as described 
by the manufacturer and optical density was read at 590nm. Iron 
concentrations were then calculated according to the manufacturer’s 
instructions. 
 
2.13.2: Inductively Coupled Plasma Mass Spectrometry 
Iron concentration in bacterial samples was analysed by Inductively 
Coupled Plasma Mass Spectrometry (ICP-MS). This was carried out by 
Dr. Uwe Gbureck at the University of Würzburg in Germany. 
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2.14: Haemolysin Assay 
 
Phenotypic confirmation of the newly transduced α- and γ-haemolysin 
mutants was achieved using a defibrinated rabbit blood (TCS Biosciences) 
assay. Bacteria were grown aerobically overnight at 37ºC in LB medium. 
The OD600 reading was taken and cells were then centrifuged (5,000 x g) 
at 4ºC. The supernatant was filter sterilised to remove any remaining 
bacterial cells. 50μl of supernatant was then added to 950μl of haemolysin 
buffer (0.145mM NaCl and 20mM CaCl2) and 25μl rabbit blood, and mixed 
by inverting. Samples were incubated for 15 minutes at 37ºC and then 
centrifuged (13,000 rpm) for 1 minute in a tabletop micro litre centrifuge 
(Heraeus Biofuge Pico). The OD543 of the supernatant was then taken 
(1ml haemolysin buffer and 25μl rabbit blood used as blank). 
 
Haemolysin activity was calculated as follows: 
 
OD543  x  1000 / OD600  x  50  x  0.5  x  15 
 
 
2.15: Tissue Culture and Cell Invasion Assay 
 
2.15.1: Maintenance of Cell Line 
A human respiratory tract epithelial cell line, A549, was used in all cell 
invasion assays. A549 cells were routinely cultured in Dulbecco modified 
Eagle medium (DMEM; Sigma) supplemented with 10% foetal bovine 
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serum (Gibco), 2mM L-glutamine, 5μg ml−1 insulin, 1μg ml−1 
hydrocortisone, 100 U ml−1 penicillin and 100μg ml−1 streptomycin 
(Sigma). Cells were grown at 37ºC with 5% CO2. 
 
2.15.2: Trypsinisation of Monolayer Cultures 
Confluent cells were re-seeded into new tissue culture flasks as follows. 
Medium was removed and cells were washed 3 times with 10ml PBS. 2ml 
trypsin-EDTA was then added to the flask, which was incubated at 37ºC 
with 5% CO2 for 5 minutes. During this incubation period, the flask was 
intermittently tapped to aid detachment. 8ml fresh medium was added to 
the flask and cells were resuspended by flushing with a sterile pipette. 2ml 
of this cell suspension was then used to seed 20ml fresh medium in a 
fresh tissue culture flask. Flasks were then incubated at 37ºC with 5% 
CO2. 
 
2.15.3: Cell Invasion Assay 
Bacteria harbouring expression vectors were grown statically overnight at 
30ºC in HEPES-buffered Dulbecco modified Eagle medium (DMEM; 
Sigma) plus 10% (v/v) RPMI, the appropriate antibiotic and 5nM (Ala5)AIP-
1 (McDowell et al., 2001). Bacteria were centrifuged (5,000 x g) and then 
washed with an equal volume fresh medium to remove the (Ala5)AIP-1. 
Following a further centrifugation step (5,000 x g) bacteria were 
concentrated 10 fold in DMEM.  This suspension was used to inoculate 
fresh invasion medium (5μg ml−1 chloramphenicol) to a final  OD600 of 0.8 
– 1.0. 
  51 
Tissue culture cells were seeded into a 96-well tissue culture microtiter 
plate in DMEM (without antibiotic) and grown overnight at 37°C in 5% CO2 
to achieve monolayers. The following morning the medium was removed 
and replaced with fresh DMEM (HEPES buffered). Cells were then 
incubated for 1 hour at 37°C in 5% CO2 before infection with 200μl of the 
prepared bacterial inoculum. The plate was centrifuged for 20 minutes 
(1,000 x g) to facilitate interaction of the bacteria with the eukaryotic cell 
surface. The plate was then incubated at 37°C for 1 hour to allow 
internalisation of the bacteria. For removal of external bacterial cells, 
tissue culture cell monolayers were washed 3 times with fresh DMEM in 
an automated plate washer (Cellwash, Thermo Labsystems) and 
monolayers were then incubated for 20 minutes at 37°C with 200μl of 
DMEM containing lysostaphin (10 μg ml-1; Sigma). Monolayers were 
washed again as before, and 200μl HEPES-buffered DMEM containing 
lysostaphin (2 μg ml-1; Sigma) was added to each well. The tissue culture 
plate was incubated at 37°C in a Tecan Genios Pro multifunctional 
detector (Perkin-Elmer Instruments), where fluorescence or 
bioluminescence and absorbance were monitored over a 24 hour period. 
 
 
2.16: Animal Work 
 
Female BALB/c mice were obtained from Harlan (Borchen, Germany). 
Five- to six-week-old female mice were injected subcutaneously with 3.3 x 
104 murine 4T1 mammary cancer cells (ATCC: CRL-2539) re-suspended 
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in 100µl PBS. Bacteria were grown in 5ml of LB broth containing 5μg ml-1 
chloramphenicol until reaching an OD600 of 0.4 (corresponding to 
approximately 2 x 108 CFU ml-1) and washed twice in PBS. The 
suspension was then diluted to approximately 1 x 107 CFU ml-1 and 100µl 
injected into the lateral tail vein of 4T1 tumour-bearing BALB/c mice 14 
days post cell implantation. Bioluminescence from the mice was monitored 
with a Nightowl CCD (Berthold) imaging system equipped with isoflurane 
anaesthesia. 
 
All animal experiments were carried out in accordance with protocols 
approved by the “Regierung von Unterfranken” (Würzburg, Germany). 
After sacrificing the mice, organs were removed and homogenised with 
PBS for plating at various dilutions. Histology was performed using an 
anti-Protein A antibody followed by a FITC labelled secondary antibody. 
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3.0: CONSTRUCTION AND IN V ITRO EVALUATION 
OF AN MRI  REPORTER IN S. AUREUS 
 
3.1: Objectives 
 
At present few imaging modalities exist which enable the non-invasive in 
vivo detection of bacterial reporter gene expression while offering detailed 
anatomical information. One of the main aims of this study, therefore, is to 
develop such a modality by the construction and in vitro evaluation of an 
MRI bacterioferritin reporter gene for S. aureus. 
 
 
3.2: Introduction 
 
3.2.1: Promoters: P3, PS10 and PahpC 
In the agr quorum sensing system, two promoters, P2 and P3, drive 
expression of two divergent transcriptional units, RNAII and RNAIII, 
respectively. The agrBDCA operon encodes the proteins involved in the 
quorum sensing system: AgrB, AgrD, AgrC and AgrA. AgrB, the 
processing enzyme, is a transmembrane protein responsible for the 
modification of the N- and C- terminals of the propeptide, AgrD, via 
cleavage and condensation, resulting in the formation of the autoinducing 
peptide (AIP). Together, AgrC and AgrA form the two-component 
regulatory system. AgrC is a transmembrane histidine-protein kinase 
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which acts as the receptor for the AIP. Upon binding the AIP, AgrC is 
phosphorylated, stimulating the transcriptional activator, AgrA. AgrA in turn 
activates the two promoters, P2 and P3, causing increased transcription of 
the P2 and P3 operons at high cell densities (Yarwood and Schlievert, 
2003). 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.1: 
Schematic representation of the Staphylococcal quorum sensing system showing the agr 
locus and its regulatory pathways (Chan et al., 2004). 
 
 
Activation of the P3 promoter by AgrA causes an increase in the P3 
transcript, RNAIII, in the bacterial cell. RNAIII, the effector molecule, acts 
at the transcriptional level, increasing expression of secreted bacterial 
proteins including haemolysins and toxic-shock syndrome toxin (Yarwood 
and Schlievert, 2003). 
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The PS10 controls transcription of the ribosomal protein gene, rpsJ, within 
bacteria including E. coli, Bacillus subtilis and S. aureus. As a functional 
part of the 30S ribosomal subunit, the gene product, S10, is necessary for 
transcription to take place within the bacteria, and as such the PS10 can be 
used as a marker for growth, due to its constitutive expression during 
bacterial replication. 
 
The PahpC controls transcription of the S. aureus ahpC gene, a homologue 
of the E. coli ahpC gene which encodes part of an alkyl hydroperoxidase 
reductase involved in protection from oxidative stress. In S. aureus the 
gene product shows homology with that of E. coli at the amino acid and 
secondary protein structure levels, and appears to be expressed in 
response to osmotic stress (Armstrong-Buisseret et al., 1995). 
 
3.2.2: E. coli Bacterioferritin 
Previous evaluation of a variety of bacterial ferritin-like proteins, namely 
bfr, fri and ftn, was carried out by Hill et al. (manuscript in preparation) for 
their potential use as MRI reporter genes in prokaryotic studies. Their 
investigation showed that E. coli BFR had the strongest effect on T2 
relaxation rates. For these reasons, E. coli BFR was chosen as the ferritin 
of choice for incorporation into an S. aureus MRI reporter gene system. 
 
3.2.3: The lux Operon 
Light is naturally emitted by some bacteria due to presence of an operon 
consisting of five genes, the luxCDABE operon. A luciferase encoded by 
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luxAB catalyses the oxidation of FMNH2 and a long-chain fatty aldehyde 
which is synthesised by the luxCDE encoded fatty acid reductase. The lux 
operon is widely used experimentally to create bioluminescence in a 
variety of bacterial species. However, use of the operon in this way has 
been largely restricted to Gram negative bacteria, since all known naturally 
occurring bioluminescent bacteria are also Gram negative, making 
expression of bioluminescence genes in genetically differing Gram positive 
bacteria more difficult. However, modified lux operons with inserted Gram 
positive RBS have now allowed bioluminescence to be used in Gram 
positive organisms at a range of temperatures without the need for an 
exogenous substrate, thus overcoming this issue (Francis et al., 2000). 
 
 
3.3: Results 
 
3.3.1: Construction and Evaluation of Expression Vectors with 
various Constitutive Promoters 
For the construction of the MRI reporters two inducible promoters were 
selected, S. aureus P3 and PahpC, for in vitro evaluation. Additionally, a 
constitutive promoter was also required for use in in vivo experiments, and 
as such, the S. aureus and B. subtilis PS10 were chosen for analysis. The 
B. subtilis PS10 consists of two adjacent promoter regions, increasing the 
likelihood that expression of genes downstream of this promoter will be 
transcribed constitutively during growth (Li et al., 1997). Two new 
expression vectors, pUNK1 Bs PS10-dual-term and pUNK1 Sa PS10-dual-
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term, were constructed using the existing Gateway® entry clones, pDONR 
P4-P1R Bs PS10, containing the B. subtilis PS10, pDONR P4-P1R Sa PS10, 
containing the S. aureus PS10, pDONR P221 dual and pDONR P2R-P3 
term. These entry clones were combined in LR reactions with the 
destination vector pDEST-pUNK1 to create pUNK1 Bs PS10-dual-term and 
pUNK1 Sa PS10-dual-term. For comparison with these new expression 
vectors for selection of the promoter which gives the highest levels of 
transcription as indicated by bioluminescence, an existing expression 
vector, pUNK1 PxylA-dual-term was used. The xylA gene is involved in the 
regulation of expression of xylose utilization genes in Bacillus megaterium, 
and without its cognate repressor, xylR, is constitutively expressed in the 
absence of xylose (Rygus et al., 1991). 
 
All expression vectors were transformed into S. aureus RN4220 by 
electroporation with selection on LB agar supplemented with 5µg ml-1 Erm. 
Transformants were then streaked onto LB agar supplemented with 5µg 
ml-1 Erm and analysed for bioluminescence using an EG & G Berthold 
luminograph (LB980). Light colonies were re-plated and colonies picked 
for subjection to plasmid DNA preparation. This DNA was then 
transformed into S. aureus RN6390 by electroporation with selection on 
LB agar supplemented with 5µg ml-1 Erm. Again, transformants were 
streaked onto LB agar supplemented with 5µg ml-1 Erm and analysed for 
bioluminescence using an EG & G Berthold luminograph (LB980). Light 
colonies were re-plated and colonies picked for use in a growth curve. The 
growth curve was carried out in a Tecan Genios Pro multifunctional 
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detector (Perkin-Elmer Instruments), where bioluminescence and 
absorbance were monitored. 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.2: Bioluminescence as relative light units (RLU) divided by optical density 
(OD) of S. aureus RN6390 pUNK1 Sa PS10-dual-term (●), pUNK1 Bs PS10-dual-term (●) 
and pUNK1 PxylA-dual-term (●). This data relates to the left y axis.  Absorbance of S. 
aureus RN6390 pUNK1 Sa PS10-dual-term (▲), pUNK1 Bs PS10-dual-term (▲) and pUNK1 
PxylA-dual-term (▲) is also shown. This data relates to the right y axis. Results represent 
the mean value of 3 data points for each reading. 
 
 
The growth curve illustrated in Figure 3.2 shows that, when normalised for 
growth, the S. aureus PS10 gives the highest levels of bioluminescence. 
Taken into account with the fact that Sa PS10 is a native S. aureus 
promoter, this promoter was chosen for the MRI reporter constructs. From 
this point onward this promoter will be referred to as PS10 as opposed to 
Sa PS10. 
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3.3.2: Construction of pUNK1 PS10-bfr-luxterm, pUNK1 P3-bfr-luxterm 
and pUNK1 PahpC-bfr-luxterm for use as MRI Reporters in S. aureus 
Primers were designed to amplify the lux cassette along with a 
downstream terminator sequence (rrnBT1T2) which occur in succession in 
an existing vector, pSB3010. Specific attB sites were also integrated into 
the primers to allow for BP reactions with Gateway® entry clones. PCR 
was carried out with the existing vector to yield product that was then used 
in BP reactions to create pDONR P2R-P3 luxterm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.3: pUNK1 PS10-bfr-luxterm. 
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Along with the previously existing Gateway® entry clones pDONR P4-P1R 
P3, pDONR P4-P1R Sa PS10, pDONR P4-P1R PahpC and pDONR P221 bfr 
(Table 2.1), these newly constructed entry clones were used in LR 
reactions with the destination vector pDEST-pUNK1 to create pUNK1 
PS10-bfr-luxterm, pUNK1 P3-bfr-luxterm and pUNK1 PahpC-bfr-luxterm 
(Figure 3.3). 
 
3.3.3: Evaluation of pUNK1 PS10-bfr-luxterm, pUNK1 P3-bfr-luxterm 
and pUNK1 PahpC-bfr-luxterm 
The newly constructed pUNK1 PS10-bfr-luxterm and pUNK1 P3-bfr-luxterm 
plasmids were dialysed before transformation into E. coli TOP10 by 
electroporation, and selection on LB agar supplemented with 150µg ml-1 
Erm. Transformants were then streaked onto LB agar supplemented with 
150µg ml-1 Erm and analysed for bioluminescence using an EG & G 
Berthold luminograph (LB980). Light colonies were re-plated and colonies 
picked for plasmid DNA preparation and confirmation by restriction 
mapping. This DNA was then transformed into S. aureus RN4220, with 
selection on LB agar supplemented with 5µg ml-1 Erm, and 
bioluminescence screening and plasmid DNA preparation as described 
above. This DNA was then transformed into S. aureus RN6390, with 
selection on LB agar supplemented with 5µg ml-1 Erm, and 
bioluminescence screening, plasmid DNA preparation and confirmation by 
restriction mapping as described above. 
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3.3.3.1: Growth Curves 
Growth curves were carried out to evaluate the in vitro transcription of the 
MRI reporter gene operon by analysis of bioluminescence. Additionally, S. 
aureus pUNK1 P3-bfr-luxterm was grown with varying concentrations of 
the P3 promoter inducer, AIP-1, and the promoter inhibitor, (Ala5)AIP-1, to 
determine optimal conditions for promoter control (McDowell et al., 2001). 
S. aureus pUNK1 PahpC-bfr-luxterm was grown with varying concentrations 
of NaCl, a known promoter inducer (Armstrong-Buisseret et al., 1995). 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
FIGURE 3.4: Bioluminescence measured from growth of S. aureus pUNK P3-bfr-luxterm 
in the presence of varying concentrations of promoter inducer (AIP) and inhibitor 
((Ala5)AIP-1). Results represent single readings. 
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As is clear in Figure 3.4, the P3 promoter is successfully induced with 
increasing concentrations of AIP-1. The bioluminescence readings from 
the pUNK1 P3-bfr-luxterm construct also indicate transcription of the 
reporter system in vitro. Although the PahpC is also clearly induced by 
concentrations of NaCl between 0.4-1M (Figure 3.5), these induced levels 
of bioluminescence peak below 8000 RLU/OD600. Comparing this to the P3 
construct, it is clear that higher levels of light can be induced in the P3 
construct, making it more suitable for in vivo studies where the tissue 
penetration of light can be a problem. It was therefore decided at this point 
to proceed with the two expression vectors, pUNK1 P3-bfr-luxterm and 
pUNK1 PS10-bfr-luxterm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.5: Bioluminescence measured from growth of S. aureus pUNK PahpC-bfr-
luxterm in the presence of varying concentrations of NaCl (M). Results represent single 
readings. 
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3.3.3.2: SDS-PAGE of S. aureus Lysates from Reporter Constructs 
To confirm translation of BFR, SDS-PAGE gels were carried out. Cultures 
of S. aureus harbouring the MRI reporter vectors were grown both with 
and without the presence of the promoter inducer, where appropriate; for 
the PahpC and P3 promoters these were NaCl at 0.4M and AIP-1 at 
5000nM, respectively. S. aureus harbouring the P3 promoter construct was 
also grown in the presence of (Ala5)AIP-1 at 5000nM, an inhibitor of the 
transcription of this promoter. Cell lysates were prepared from these 
cultures for SDS-PAGE analysis. 
 
SDS-PAGE gels of these samples suggest that the bfr genes in the 
expression vectors are being translated (Figure 3.6). A band of the correct 
size for the bacterioferritin protein (~20kD) can be seen in both the E. coli 
strain alone, which will produce its own bacterioferritin, and to a heavier 
extent in the E. coli pUNK1 PS10-bfr-luxterm strain. In the S. aureus 
RN6390 strain, no band is present, which is consistent with the fact that S. 
aureus does not produce its own bacterioferritin. Similarly, the control S. 
aureus RN6390 strain harbouring pUNK1 PS10-dual-term, a plasmid of 
similar size to the bfr expression vectors, does not show a band. However, 
all of the S. aureus RN6390 harbouring bfr expression vectors show a 
band of equal size to those present in the E. coli strains. Interestingly, 
despite equal loading of samples in each lane, the strains grown in the 
presence of promoter inducers do not appear to produce any more 
bacterioferritin than those without inducer or indeed with inhibitor. 
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FIGURE 3.7: Western blot of S. aureus pUNK1 PS10-bfr-luxterm and S. aureus pUNK1 
P3-bfr-luxterm treated with anti-BFR antibody. Positive control (+) purified E. coli BFR, 
negative control (-) S. aureus RN6390. Figure shows (A) ponceau stain after blotting and 
(B) western developed for 800 seconds. Arrows indicate bands representing the BFR 
protein. 
 
 
Western blots were carried out to confirm that the bands seen on the SDS-
PAGE gels were in fact bacterioferritin and not a different protein, which 
would explain the apparent lack of inducibility seen in the SDS-PAGE gels 
above. A primary rabbit polyclonal antibody against E. coli BFR was used 
with a horseradish peroxidise-linked secondary goat anti-rabbit antibody. 
The Western blot suggests that the bands seen on the SDS-PAGE gels of 
the correct size are bacterioferritin, indicating that the expression vectors 
are being translated in vitro (Figure 3.7) 
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3.3.3.4: Sequencing 
Due to the cross-reactivity of the primary antibody which can be seen in 
Figure 3.7 B, the same samples were again used for SDS-PAGE and the 
suspected bacterioferritin bands were excised from the gel and sent for 
sequencing by matrix-assisted laser desorption/ionization mass 
spectrometry (MALDI-MS). The SDS-PAGE gel can be seen in Figure 3.8. 
Results indicated that the bands were bacterioferritin, with the top score 
for both samples being a match with the E. coli bacterioferritin protein 
(Figure 3.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.8: SDS-PAGE gel of S. aureus pUNK1 PS10-bfr-luxterm and S. aureus pUNK1 
P3-bfr-luxterm indicating bands sent for sequencing within the red boxes. 
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Top Score: 133 for gi|16131215, bacterioferritin, iron storage and 
detoxification protein [Escherichia coli str. K-12 substr. MG1655] 
 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
Top Score: 149 for gi|16131215, bacterioferritin, iron storage and 
detoxification protein [Escherichia coli str. K-12 substr. MG1655] 
 
 
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.9: Sequencing results represented as a Probability Based Mowse Score 
where the protein score is -10*Log(P), where P is the probability that the observed match 
is a random event. Protein scores greater than 81 are significant (p<0.05). (A) Results for 
band excised from SDS-PAGE gel of S. aureus pUNK1 P3-bfr-luxterm sample and (B) 
results for band excised from SDS-PAGE gel of S. aureus pUNK1 PS10-bfr-luxterm 
sample. 
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3.3.3.5: ICP-MS 
With confirmation of the successful expression of BFR, ICP-MS was 
carried out on the same samples to determine the amount of iron present 
in the bacterial cells as an indicator of the BFR function. The results 
showed no increase in iron concentrations within S. aureus RN6390 
harbouring the MRI reporter vectors, suggesting that in S. aureus the 
bacterioferritin is non-functional and is not loading with iron (Table 3.1). 
 
In the E. coli genome, the bfr gene is located downstream of a bfd gene, 
whose product, a [2Fe-2S] protein, forms a complex with BFR. Although 
the function of this protein is unknown, it has been hypothesised that it 
may participate in the iron storage function of BFR (Garg et al., 1996). 
This theory would explain the lack of function of the bacterioferritin 
translated in S. aureus, while the E. coli strains harbouring the MRI 
reporter collect more iron due to their native bfd. 
 
 
TABLE 3.1: ICP-MS data showing iron concentration of cell lysates of S. aureus 
harbouring pUNK1 PS10-dual-term and pUNK1 PS10-bfr-luxterm. Figures represent single 
samples. 
Strain I ron  ( µg/ L)  
S. aureus pUNK1  PS1 0 -dual- term  1213 
S. aureus pUNK1  PS1 0 -b fr- luxterm  758 
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3.3.4: Construction of pUNK1 PS10-bfd/bfr-luxterm and pUNK1 P3-
bfd/bfr-luxterm for use as MRI Reporters in S. aureus 
To test this hypothesis, new reporter plasmids were constructed 
incorporating the bfd gene, a potential iron loader. Primers were designed 
to amplify the bfd gene alone and the bfd gene along with the bfr gene 
from E. coli. Specific attB sites were also integrated into the primers to 
allow for BP reactions with Gateway® entry clones. PCR was carried out 
with E. coli TOP10 lysates to yield product that was then used in BP 
reactions to create pDONR P221 bfd and pDONR P221 bfd/bfr. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.10: pUNK1 PS10-bfd/bfr-luxterm 
  70 
Along with the previously existing Gateway® entry clones pDONR P4-P1R 
P3 and pDONR P4-P1R Sa PS10, and the entry clone constructed for this 
study, pDONR P2R-P3 luxterm, these newly constructed entry clones 
were used in LR reactions with the destination vector pDEST-pUNK1 to 
create pUNK1 PS10-bfd-luxterm, pUNK1 PS10-bfd/bfr-luxterm and pUNK1 
P3-bfd/bfr-luxterm (Figure 3.10). 
 
3.3.5: Evaluation of pUNK1 PS10-bfd/bfr-luxterm and pUNK1 P3-
bfd/bfr-luxterm 
The newly constructed pUNK1 PS10-bfd-luxterm, pUNK1 PS10-bfd/bfr-
luxterm and pUNK1 P3-bfd/bfr-luxterm plasmids were dialysed before 
transformation into E. coli TOP10 by electroporation, and selection on LB 
agar supplemented with 150µg ml-1 Erm. Transformants were then 
streaked onto LB agar supplemented with 150µg ml-1 Erm and analysed 
for bioluminescence using an EG & G Berthold luminograph (LB980). Light 
colonies were re-plated and colonies picked for subjection to plasmid DNA 
preparation. This DNA was then transformed into S. aureus RN4220, with 
selection on LB agar supplemented with 5µg ml-1 Erm, and 
bioluminescence screening and plasmid DNA preparation as described 
above. This DNA was then transformed into S. aureus RN6390, with 
further selection on LB agar supplemented with 5µg ml-1 Erm, 
bioluminescence screening and plasmid DNA preparation. 
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3.3.5.1: SDS-PAGE of E. coli and S. aureus Lysates from bfr and 
bfd/bfr Reporter Constructs 
To confirm translation of bacterioferritin from the new expression vectors, 
SDS-PAGE gels were carried out. Cultures of E. coli transformed with 
pUNK1 PS10-dual-term, pUNK1 PS10-bfd-luxterm, pUNK1 PS10-bfr-luxterm 
and pUNK1 PS10-bfd/bfr-luxterm were grown and cell lysates prepared. 
During this process, 1ml of each sample was centrifuged to analyse pellet 
colour, since E. coli is known to change to a pink colour when BFR is 
expressed due to the haem molecules within the protein. 
 
 
 
 
 
 
 
 
FIGURE 3.11: Pellets from the centrifugation of 1ml culture of E. coli harbouring (A) 
pUNK1 PS10-dual-term, (B) pUNK1 PS10-bfd-luxterm, (C) pUNK1 PS10-bfr-luxterm and (D) 
pUNK1 PS10-bfd/bfr-luxterm. 
 
 
As can be seen in Figure 3.11, the E. coli pUNK1 PS10-bfr-luxterm and 
pUNK1 PS10-bfd/bfr-luxterm pellets are pinker in colour than the other 
samples, indicating that BFR is being translated in vitro by the new 
expression vectors. A pinker pellet would be expected in samples 
A B C D
  72 
harbouring expression vectors containing the bfr gene, due to increased 
amounts of BFR. However, the colour of the E. coli pUNK1 PS10-bfd/bfr-
luxterm pellet is significantly pinker than that of E. coli pUNK1 PS10-bfr-
luxterm, indicating that the bfd gene may in some way enhance translation 
of the bfr gene. If this were the case, then the deep pink colour could be 
attributed to the fact that this expression vector contains both the bfd and 
bfr genes, resulting in increased amounts of BFR production in this 
sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.12: SDS-PAGE gel of E. coli and S. aureus RN6390 harbouring pUNK1 PS10-
dual-term, pUNK1 PS10-bfd-luxterm, pUNK1 PS10-bfr-luxterm and pUNK1 PS10-bfd/bfr-
luxterm. Arrows indicate the thicker bacterioferritin bands seen in the E. coli pUNK1 PS10-
bfd/bfr-luxterm sample and the S. aureus pUNK1 PS10-bfr-luxterm sample. 
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To determine concentrations of bacterioferritin within each sample, 
cultures of S. aureus RN6390 harbouring the new MRI reporter vectors 
were also grown and were normalised to an OD600 of 0.5. Cell lysates 
prepared from these cultures were used in SDS-PAGE analysis with the E. 
coli samples. 
 
SDS-PAGE gels of the E. coli samples used for pellet analysis also 
suggest that the pink colour seen in the pellet from centrifugation of the E. 
coli pUNK1 PS10-bfd/bfr-luxterm was due to an increase in the amount of 
BFR, due to the thicker band seen on the gel for this sample (Figure 3.12). 
 
Interestingly, unlike the E. coli samples, the S. aureus harbouring the 
pUNK1 PS10-bfr-luxterm is the sample which produced the most 
bacterioferritin, with no visible band seen in the S. aureus pUNK1 PS10-
bfd/bfr-luxterm sample. As would be expected, the S. aureus pUNK1 PS10-
bfd-luxterm did not see any bacterioferritin synthesised as S. aureus does 
not have a bacterioferritin gene within its genome. However, it would be 
expected that the bfr gene within the expression vector pUNK1 PS10-
bfd/bfr-luxterm would be expressed, causing the synthesis of 
bacterioferritin. All samples contained the same quantity of protein so this 
could not explain the lack of bacterioferritin seen in the S. aureus pUNK1 
PS10-bfd/bfr-luxterm sample. 
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3.3.5.2: Iron Assay 
Before cell lysates were prepared for SDS-PAGE analysis as described, 
samples of the bacterial cultures were taken and subjected to the 
QuantiChromTM Iron Assay. 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.13: Iron levels of cell lysates of S. aureus and E.coli harbouring pUNK1 PS10-
dual-term (dual), pUNK1 PS10-bfr-luxterm (bfr) and pUNK1 PS10-bfd/bfr-luxterm (bfd/bfr). 
 
 
As can be seen in Figure 3.13, higher concentrations of iron were present 
in cell lysates of E. coli harbouring expression vectors with the 
incorporated bfr gene, suggesting that the BFR being produced is 
functional and is binding iron. Presence of the bfd did not appear to 
increase iron concentrations, even with more BFR in this sample, but this 
could be due to sufficient gene product from the native E. coli bfd, and so 
a role for the bfd gene product in iron loading can not be determined from 
this data. In contrast to previous ICP-MS analysis of S. aureus strains 
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harbouring bfr expression vectors, the iron assay clearly demonstrates an 
almost 5 fold increase in iron concentrations in S. aureus pUNK1 PS10-bfr-
luxterm. However, although some iron appears to have been collected in 
the S. aureus pUNK1 PS10-bfd/bfr-luxterm strain, it is to a much lesser 
extent than that seen in S. aureus pUNK1 PS10-bfr-luxterm. Despite this, 
an iron loading role for bfd cannot be ruled out, since SDS-PAGE analysis 
showed that the pUNK1 PS10-bfd/bfr-luxtrem plasmid does not appear to 
cause synthesis of large amounts of bacterioferritin. The lack of iron 
collection could therefore be due to a lack of bacterioferritin rather than 
due to the lack of iron loading. 
 
3.3.5.3: ICP-MS 
Due to the differences noted between data from the iron assay described 
above and the preliminary ICP-MS data carried out on the original 
expression vectors, ICP-MS was carried out again using the same 
samples prepared for the iron assay (Table 3.2). 
 
 
TABLE 3.2: ICP-MS data showing iron concentration of cell lysates of S. aureus 
harbouring pUNK1 PS10-dual-term and pUNK1 PS10-bfr-luxterm. Figures represent single 
samples. 
 
Strain I ron  ( µg/ L)  
S. aureus pUNK1  PS1 0 -dual- term  135 
S. aureus pUNK1  PS1 0 -b fr- luxterm  174 
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As with the iron assay, this data clearly shows an increase in iron 
concentration in S. aureus pUNK1 PS10-bfr-luxterm, indicative of 
functioning BFR in this strain. 
 
3.3.5.4: Evaluation of Plasmid Loss 
In order to determine the reason for the lack of iron collection seen in the 
S. aureus pUNK1 PS10-bfd/bfr-luxterm strain, the S. aureus samples were 
grown both with and without antibiotic selection to establish any potential 
role played by plasmid loss due to inactivation of antibiotic (Figure 3.14). 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.14: Iron levels in cell lysates of S. aureus pUNK1 PS10-dual-term (dual), 
pUNK1 PS10-bfr-luxterm (bfr) and pUNK1 PS10-bfd/bfr-luxterm grown in the presence of 
5µg ml-1 Erm (black columns) and without antibiotics (striped columns). 
 
 
Some plasmid loss appears to have occurred in both S. aureus pUNK1 
PS10-bfr-luxterm and pUNK1 PS10-bfd/bfr-luxterm as indicated by the 
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reduced iron concentrations in cell lysates from cultures grown without 
antibiotic present. However, SDS-PAGE analysis of the same samples 
suggests that despite potential plasmid loss, both strains grown with and 
without antibiotic selection appear to make the same quantity of protein, 
which implies that plasmid loss is not the cause of reduced iron collection 
in S. aureus pUNK1 PS10-bfd/bfr-luxterm (Figure 3.15). 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.13: SDS-PAGE gel of S. aureus harbouring pUNK1 PS10-dual-term, pUNK1 
PS10-bfd-luxterm, pUNK1 PS10-bfr-luxterm and pUNK1 PS10-bfd/bfr-luxterm grown with 
(5µg ml-1 Erm) and without antibiotic selection. 
 
 
3.3.5.5: Sequencing 
To ensure there were no mutations within the plasmid that may be 
responsible for the lack of production of BFR, a sample of the plasmid 
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DNA prepared from S. aureus RN6390 was sent for sequencing. The 
sequencing revealed no mutations within the plasmid, indicating that this 
was not a cause for the failed expression of BFR. 
 
3.3.5.6: Bioluminescence Assays to Determine any Interference of 
Transcription or Translation due to bfd Gene 
The apparent BFR expression and iron collection in the S. aureus pUNK1 
PS10-bfr-luxterm strain demonstrates the ability for the in vivo expression of 
the MRI reporter in S. aureus, and the functionality of the translated BFR. 
Taking this into account, it would appear that the bfd is perhaps affecting 
the transcription or translation of the downstream bfr in the pUNK1 PS10-
bfd/bfr-luxterm reporter. 
 
The bfd gene is not native to S. aureus strains. It is therefore possible that 
this gene contains a transcription terminator sequence recognised in S. 
aureus, causing termination of transcription before the ribosome reaches 
the bfr gene. If this is the case, then no light would be seen from the S. 
aureus pUNK1 PS10-bfd/bfr-luxterm due to lack of transcription of the lux 
operon downstream of the bfr gene. If the presence of the bfd gene is 
somehow affecting the translation of the bfr gene, then bioluminescence 
would still be expected as the genes of the lux operon have their own 
ribosome binding sites (RBS). 
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To test this hypothesis, light assays were carried out using S. aureus 
RN6390 samples harbouring pUNK1 PS10-bfr-luxterm and pUNK1 PS10-
bfd/bfr-luxterm.  
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.16: Bioluminesce relative to growth of S. aureus harbouring pUNK1 PS10-bfr-
luxterm and pUNK1 PS10-bfd/bfr-luxterm. Results represent the mean value of 3 data 
points for each reading. 
 
 
As can be seen in Figure 3.16, S. aureus pUNK1 PS10-bfd/bfr-luxterm is 
emitting light levels similar to those from S. aureus pUNK1 PS10-bfr-
luxterm, suggesting that the lux operon in the S. aureus pUNK1 PS10-
bfd/bfr-luxterm reporter gene has been translated. This supports the 
proposal that the bfd gene is not stopping transcription of the bfr gene, but 
is more likely having some effect on the translation of the bfr gene. 
Furthermore, the fact that the levels of light are as high in the S. aureus 
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harbouring pUNK1 PS10-bfd/bfr-luxterm as they are in the S. aureus 
harbouring pUNK1 PS10-bfr-luxterm, suggests that the bfd gene is neither 
stopping nor affecting the level of transcription of the MRI reporter gene 
transcript. 
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4.0: CONSTRUCTION AND CHARACTERISATION OF 
A hlb MUTANT AND CHARACTERISATION OF 
EXIST ING HAEMOLY SIN MUTANTS IN S. AUREUS 
 
4.1: Objectives 
 
Although it is clear that agr regulated genes have a role in endosomal 
escape of internalised S. aureus, it is not fully clear which genes 
specifically are important. A number of haemolysin genes are under the 
control of the agr system, all of which have the ability to disrupt eukaryotic 
cell membranes. With these factors in mind, haemolysins appear to be 
ideal candidates in the study of genes involved in endosomal escape of 
internalised S. aureus. One of the aims of this study, therefore, was to 
determine the role of S. aureus haemolysins in endosomal escape of 
internalised S. aureus with the intention of tracking bacterial gene 
expression in vivo using MRI expression vectors developed in this study. 
 
 
4.2: Introduction 
 
As described earlier, S. aureus has been shown to demonstrate 
intracellular survival strategies, with the ability to become internalised by, 
and persist within, a wide range of non-professional eukaryotic 
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phagocytes. Once internalisation has occurred, S. aureus is situated in a 
host membrane-bound endosome. However, S. aureus has been shown to 
have the ability to escape this endosome, residing and potentially 
replicating in the host cell cytoplasm (Bayles et al., 1998; Wesson et al., 
1998). S. aureus replication within bovine mammary epithelial cells has 
been demonstrated by Qazi et al. (2004) using fluorescently labelled 
bacteria and time-lapse confocal microscopy. S. aureus has also been 
shown to replicate intracellularly within a human pulmonary epithelial cell 
line (Kahl et al., 2000). 
 
Although it has been shown that internalised S. aureus breach the 
endosome, the mechanisms via which this escape occurs are not well 
understood. Wesson et al. (1998) have suggested a model describing a 
role for agr-regulated quorum sensing in S. aureus internalisation and 
endosomal escape. The model proposes that before internalisation, the 
autoinducer peptide (AIP) levels are low, due to dilution into surrounding 
extracellular fluids, resulting in expression of cell-surface associated 
adherence factors by S. aureus. Expression of such factors at this stage 
facilitates binding of S. aureus to host cell surfaces, thus promoting 
internalisation. Once internalised, the bacteria are bound within an 
endosome, within which concentrations of the AIP increase, triggering agr 
expression, and subsequently production of the many exoproteins up-
regulated by this quorum sensing system. It is thought that some of these 
exoproteins then function in endosomal escape. This model is supported 
by the observation that an agr mutant, S. aureus RN6911, which produces 
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increased levels of cell surface binding proteins and lower amounts of 
exoproteins, was internalised at higher efficiencies in bovine mammary 
epithelial cells than the wild-type strain, but was unable to replicate 
intracellularly (Wesson et al., 1998; Qazi et al., 2004). 
 
 
4.3: Results 
 
4.3.1: Construction of pTS1-Dest hlb for use in S. aureus 
Mutagenesis 
Primers were designed to amplify approximately 1000bp of both the 
upstream and downstream regions flanking the hlb gene responsible for 
the production of β-haemolysin from S. aureus RN6390 genomic DNA. 
Specific attB sites were also integrated into the primers to allow for BP 
reactions with Gateway® entry clones. S. aureus RN6390 genomic DNA 
was used in PCR with the newly designed primers yielding product which 
was used in BP reactions, creating pDONR P4-P1R::hlb up and pDONR 
P2R-P3::hlb down (Figure 4.1 A and Figure 4.2 A). These new entry 
clones were transformed into E. coli TOP10 by electroporation with 
selection on LB agar supplemented with 50µg ml-1 Km. Transformants 
were then streaked onto fresh LB agar supplemented with 50µg ml-1 Km 
and colonies picked for plasmid DNA preparation and confirmation by 
restriction mapping. 
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A 
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FIGURE 4.1: (A) pDONR P4-P1R::hlb up and (B) agarose gel electrophoresis of pDONR 
P4-P1R::hlb up fragments, after restriction with ApaI, EcoRV and PmeI. 
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FIGURE 4.2: (A) pDONR P2R-P3::hlb down and (B) agarose gel electrophoresis of 
pDONR P2R-P3::hlb down fragments, after restriction with ApaI, EcoRV and PmeI. 
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Bands of the sizes expected after analysis of the new plasmid maps 
constructed using Vector NTI software (Invitrogen) were visualised on an 
agarose gel by electrophoresis, indicating that the BP reactions were 
successful (Figure 4.1 B and Figure 4.2 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.3: pDONR P221 ery PhiC 
 
 
Along with pDONR p221 ery PhiC (Figure 4.3), these newly constructed 
entry clones were used in an LR recombination reaction with a Gateway® 
destination vector, pTS1-Dest +lac, to create pTS1-Dest hlb (Figure 4.4 A 
and Figure 4.5). 
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FIGURE 4.4: (A) pDTS1-Dest hlb and (B) agarose gel electrophoresis of pDTS1-Dest hlb 
fragments, after restriction with PmeI, SacI, BamHI, NcoI, and PstI. White arrows are 
present to highlight less visible bands. 
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This new plasmid was transformed into E. coli TOP10 by electroporation 
with selection on LB agar supplemented with 100µg ml-1 Amp. 
Transformants were then streaked onto fresh LB agar supplemented with 
100µg ml-1 Amp and colonies picked for plasmid DNA preparation and 
confirmation by restriction mapping. 
 
Bands of the sizes expected after analysis of the new plasmid map 
constructed using Vector NTI software (Invitrogen) were visualised on an 
agarose gel by electrophoresis, indicating that the LR recombination 
reaction was successful (figure 4.4 B). 
 
4.3.2: Mutagenesis in S. aureus using pTS1-Dest hlb 
The newly constructed pTS1-Dest hlb was used in the mutagenesis of S. 
aureus RN6390 to create a hlb mutant with resistance to erythromycin. 
The newly constructed temperature sensitive pTS1-Dest hlb mutagenesis 
plasmid was transformed into S. aureus RN4220 by electroporation with 
selection on LB agar supplemented with 5µg ml-1 Erm and 5µg ml-1 Cm, 
and incubation overnight at 30°C. Transformants were then streaked onto 
fresh LB agar supplemented with 5µg ml-1 Erm and 5µg ml-1 Cm, 
incubated overnight at 30°C and colonies then picked for subjection to 
plasmid DNA preparation. This DNA was then transformed into S. aureus 
RN6390 by electroporation with selection on LB agar supplemented with 
5µg ml-1 Erm and 5µg ml-1 Cm. Transformants were grown overnight 
statically in LB supplemented with 5µg ml-1 Erm and 5µg ml-1 Cm at 30°C 
to facilitate recombination, followed by plating on LB agar supplemented 
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with 5µg ml-1 Erm before incubation overnight at 42°C to promote plasmid 
loss. Any colonies were replica plated onto LB agar supplemented with 
5µg ml-1 Cm and then LB agar supplemented with Erm and 5µg ml-1 
before incubation overnight at 37°C. Genomic DNA purification of colonies 
which grew on LB agar supplemented with 5µg ml-1 Erm but not Cm was 
carried out and the DNA from these putative mutants was screened by 
PCR using different primers to confirm the occurrence of a double cross. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.6: Schematic diagram showing the annealing sites for the hlb up F’ and hlb 
down R’ primers, of S, aureus RN6390, pTS1-Dest hlb and a ∆hlb. The black line 
represents the S. aureus RN6390 genome and the blue line represents the pTS1-Dest 
hlb backbone. 
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FIGURE 4.7: Schematic diagram showing the annealing sites for the hlb outside up F’ 
and hlb outsite down R’ primers, of S, aureus RN6390, pTS1-Dest hlb and a ∆hlb. The 
black line represents the S. aureus RN6390 genome and the blue line represents the 
pTS1-Dest hlb backbone. Primers in grey text would not yield product due to lack of an 
annealing site. 
 
 
As can be seen in Figure 4.8, primers specific to regions outside of the 
1Kb upstream and downstream regions of the hlb gene incorporated in the 
pTS1-Dest hlb, give no product from the plasmid, as would be expected, 
but show product from the wild type S. aureus RN6390 and the putative 
mutant. The band from the putative mutant however, is approximately 
900bp bigger than that from RN6390, due to deletion of the 992bp long hlb 
gene and replacement with the 1.9Kb long erm cassette. Primers for the 
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hlb upstream and downstream region yield equally large bands from the 
plasmid and putative mutant, since the product should be of exactly the 
same sequence; upstream and downstream regions of hlb with the 
incorporated erm cassette. The S. aureus RN6390 shows a smaller band 
since the PCR product is simply the upstream and downstream regions 
flanking the hlb gene, without any inserted antibiotic marker (Figure 4.6 
and Figure 4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.8: Agarose gel electrophoresis showing PCR products from PCR of genomic 
DNA from S. aureus RN6390 and a putative S. aureus RN6390 hlb mutant, and pTS1-
Dest hlb plasmid DNA, using primers specific for the regions outside of the regions used 
to construct the pTS1-Dest hlb plasmid and primers specific for regions outside of the hlb 
gene which were used to construct the pTS1-Dest hlb plasmid. 
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FIGURE 4.9: Schematic diagram showing the annealing sites for the hlb up F’ and ery R’ 
primers, of S, aureus RN6390, pTS1-Dest hlb and a ∆hlb. The black line represents the 
S. aureus RN6390 genome and the blue line represents the pTS1-Dest hlb backbone. 
Primers in grey text would not yield product due to lack of an annealing site. 
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FIGURE 4.10: Schematic diagram showing the annealing sites for the ery F’ and hlb 
down R’ primers, of S, aureus RN6390, pTS1-Dest hlb and a ∆hlb. The black line 
represents the S. aureus RN6390 genome and the blue line represents the pTS1-Dest 
hlb backbone. Primers in grey text would not yield product due to lack of an annealing 
site. 
 
 
Figure 4.11 shows the presence of the erm cassette in the putative mutant 
from PCR with primers within the cassette and the 1Kb upstream and 
downstream regions flanking the hlb gene. As would be expected, PCR 
using S. aureus RN6390 yields no product since there is no erm cassette 
present within the genome (Figure 4.9 and Figure 4.10). 
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FIGURE 4.11: Agarose gel electrophoresis showing PCR products from PCR of genomic 
DNA from S. aureus RN6390 and a putative S. aureus RN6390 hlb mutant, and pTS1-
Dest hlb plasmid DNA, using primers specific for the erm cassette and primers specific for 
regions outside of the hlb gene which were used to construct the pTS1-Dest hlb plasmid. 
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FIGURE 4.12: Schematic diagram showing the annealing sites for the hlb up F’ and pTS1 
R’ primers, of S, aureus RN6390, pTS1-Dest hlb and a ∆hlb. The black line represents 
the S. aureus RN6390 genome and the blue line represents the pTS1-Dest hlb backbone. 
Primers in grey text would not yield product due to lack of an annealing site. 
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FIGURE 4.13: Schematic diagram showing the annealing sites for the pTS1 up F’ and hlb 
down R’ primers, of S, aureus RN6390, pTS1-Dest hlb and a ∆hlb. The black line 
represents the S. aureus RN6390 genome and the blue line represents the pTS1-Dest 
hlb backbone. Primers in grey text would not yield product due to lack of an annealing 
site. 
 
 
Figure 4.14 confirms the loss of the pTS1-Dest hlb plasmid from the 
putative mutant, which should not have any pTS1-Dest hlb present if a 
double cross has taken place. The lack of product yielded from PCR with 
the pTS1 primers in the putative mutant suggests that this is the case 
(Figure 4.12 and Figure 4.13). 
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FIGURE 4.14: Agarose gel electrophoresis showing PCR products from PCR of genomic 
DNA from S. aureus RN6390 and a putative S. aureus RN6390 hlb mutant, and pTS1-
Dest hlb plasmid DNA, using primers specific for the backbone of the pTS1-Dest hlb 
cassette and primers specific for regions outside of the hlb gene which were used to 
construct the pTS1-Dest hlb plasmid. 
 
 
PCR with the above illustrated six pairs of primers confirms a double cross 
with the pTS1-Dest hlb plasmid and the genome of S. aureus RN6390. 
The putative mutant also demonstrates the phenotype of erythromycin 
resistance, indicating that the mutagenesis was successful. Further 
confirmation with Western blotting would be desirable before using this 
mutant for in vivo experiments. 
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4.3.3: Excision of erm Gene in S. aureus hlb Mutant 
The erm gene was excised from the newly constructed mutant to facilitate 
the future construction of double mutants. The S. aureus RN6390 ∆hlb 
was transformed with the pTS1 intC expression vector, pSB3016, and 
xylose added to induce transcription of the expression vector. Cultures 
were then plated onto non-selective LB agar before incubation overnight at 
42°C to promote loss of the temperature sensitive pSB3016 plasmid. Any 
colonies were replica plated onto LB agar alone, LB agar supplemented 
with 5µg ml-1 Cm and LB agar supplemented with 5µg ml-1 Erm in order to 
detect clones which had lost both the chromosomal erm gene and the IntC 
expression vector. Genomic DNA purification of colonies which grew on 
LB agar alone but not LB agar supplemented with 5µg ml-1 Erm or Cm was 
carried out and the DNA was screened by PCR using various sets of 
primers to confirm the success of the excision of the erm cassette. 
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FIGURE 4.15: Schematic diagram showing the annealing sites for the hlb outside up F’ 
and hlb outside down R’ primers, of S. aureus RN6390, pTS1-Dest hlb and a ∆hlb with 
excised erm cassette. The black line represents the S. aureus RN6390 genome and the 
blue line represents the pTS1-Dest hlb backbone. Primers in grey text would not yield 
product due to lack of an annealing site. 
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FIGURE 4.16: Schematic diagram showing the annealing sites for the hlb up F’ and ery 
R’ primers, of S. aureus RN6390, pTS1-Dest hlb and a ∆hlb with excised erm cassette. 
The black line represents the S. aureus RN6390 genome and the blue line represents the 
pTS1-Dest hlb backbone. Primers in grey text would not yield product due to lack of an 
annealing site. 
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FIGURE 4.17: Agarose gel electrophoresis showing PCR products from PCR of genomic 
DNA from S. aureus RN6390 and the S. aureus RN6390 hlb mutant, and pTS1-Dest hlb 
plasmid DNA, using primers specific for regions outside of the regions used to construct 
the pTS1-Dest hlb plasmid and primers specific for regions outside of the hlb gene which 
were used to construct the pTS1-Dest hlb plasmid. 
 
 
The two sets of primers used in Figure 4.17 demonstrate the loss of the 
erm cassette from the mutant. Primers specific for regions outside of the 
1Kb upstream and downstream regions flanking the hlb gene yielded 
product from both the mutant and the wild type RN6390 suggesting 
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regions incorporated into the plasmid. The hlb up F’/ery R’ combination of 
primers again indicates loss of the erm gene, with product only present 
from the pTS1-Dest hlb plasmid as would be expected (Figure 4.15 and 
Figure 4.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.18: Schematic diagram showing the annealing sites for the ery F’ and hlb 
down R’ primers, of S. aureus RN6390, pTS1-Dest hlb and a ∆hlb with excised erm 
cassette. The black line represents the S. aureus RN6390 genome and the blue line 
represents the pTS1-Dest hlb backbone. Primers in grey text would not yield product due 
to lack of an annealing site. 
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FIGURE 4.19: Schematic diagram showing the annealing sites for the hlb up F’ and hlb 
down R’ primers, of S. aureus RN6390, pTS1-Dest hlb and a ∆hlb with excised erm 
cassette. The black line represents the S. aureus RN6390 genome and the blue line 
represents the pTS1-Dest hlb backbone. Primers in grey text would not yield product due 
to lack of an annealing site. 
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FIGURE 4.20: Agarose gel electrophoresis showing PCR products from PCR of genomic 
DNA from S. aureus RN6390 and the S. aureus RN6390 hlb mutant, and pTS1-Dest hlb 
plasmid DNA, using primers specific for regions outside of the hlb gene which were used 
to construct the pTS1-Dest hlb plasmid and primers specific for the erm cassette. 
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pTS1-Dest hlb PCR with these primers is larger than that from both S. 
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aureus RN6390 and the mutant due to the presence of the erm cassette. 
In fact, Figure 4.20 clearly shows how this PCR product is approximately 
1Kb larger than that from S. aureus RN6390 as the erm gene is 1Kb larger 
than the hlb gene. In addition, the product yielded from S. aureus RN6390 
is approximately 900bp larger than that from the mutant due to the fact 
that the mutant has neither the hlb gene nor the erm cassette present 
(Figure 4.18 and Figure 4.19). 
 
PCR with the above illustrated four pairs of primers therefore confirms the 
loss of the erm gene in the S. aureus ∆hlb. The mutant also no longer 
demonstrated the phenotype of erythromycin resistance, indicating that 
the excision was successful. 
 
4.3.4: Phenotypic Confirmation of α- and γ-Haemolysin Mutants 
Mutants in S. aureus α- and δ-haemolysin had previously been 
constructed for use in endosomal escape research. In addition to this, a γ-
haemolysin mutant was obtained from Tim Foster’s laboratory in Dublin. 
The β-haemolysin mutant was made in this study to complete the 
complement of haemolysin mutants. However, problems were experienced 
transforming the S. aureus RN6390 ∆hla with any reporter plasmids, and it 
was decided that this may be due to point mutations elsewhere within the 
genome of this strain. To overcome this issue, the mutation was 
transduced from the S. aureus RN6390 ∆hla back into S. aureus RN6390. 
Additionally, the γ-haemolysin mutation was transduced into S. aureus 
RN6390 to ensure all mutations were within the same background strain. 
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While the β-haemolysin mutant was being constructed, the phenotypes of 
the newly transduced mutations were tested for haemolytic activity. 
 
All strains were cultured in LB broth and normalised according to their 
OD600. After centrifugation, bacterial supernatants were filter sterilised and 
added to specified quantities of haemolysin buffer and rabbit blood and 
mixed by inverting. After incubation, cultures were centrifuged and the 
OD543 of the supernatant was measured. These figures were then used to 
calculate the haemolysin activity of each sample. 
 
 
TABLE 4.1: Haemolysin activity of S. aureus RN6390 ∆hla and two transduced putatives 
as compared to the wild-type S. aureus RN6390 strain. P-values indicated in relation to 
student’s t-test used to analyse data. 
 
 Haem olysin act iv ity P-value  
RN6 3 90  1.58 ±  0.02  
∆hla  0.16 ±  0.27 < 3x10 -4 
Putat ive 1  0.12 ±  0.10 < 6x10 -6 
Putat ive 2  0.04 ±  0.05 < 3x10 -7 
 
 
As illustrated above in Table 4.1, both the original S. aureus RN6390 ∆hla 
strain, and the two transduced putative ∆hla strains are significantly less 
haemolytic than S. aureus RN6390 in rabbit blood. 
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TABLE 4.2: Haemolysin activity of S. aureus 8325-4 ∆hlg and two transduced putatives 
in an S. aureus RN6390 background, as compared to the wild-type S. aureus 8325-4 
strain. P-values indicated in relation to student’s t-test used to analyse data. 
 
 Haem olysin act iv ity P-value  
8 3 2 5 - 4  1.48 ±  0.09  
∆hlg 0.00 ±  0.01 < 3x10 -6 
Putat ive 1  0.00 ±  0.00 < 6x10 -6 
Putat ive 2  0.00 ±  0.00 < 3x10 -6 
 
 
Similarly, Table 4.2 shows that both the original S. aureus 8325-4 ∆hlg 
strain, and the two transduced putative ∆hlg strains are significantly less 
haemolytic than S. aureus RN6390 in rabbit blood. However, all three 
strains appear to show no haemolytic activity, as compared with the S. 
aureus RN6390 ∆hla strains, which still showed some haemolytic activity 
as compared with the wild-type. Although both β- and δ-haemolysin are 
not specifically active against rabbit erythrocytes, α-haemolysin is active 
against rabbit erythrocytes, and subsequently some lysis would be 
expected in a ∆hlg strain still capable of producing α-haemolysin. It was 
thought that this may be due to the growth phase of bacteria used for the 
assay, and so assays were repeated with stationary phase bacterial 
cultures (data not shown). However, the same effect was seen. 
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4.3.5: Invasion Assays 
 
4.3.5.1: agr Expression and Growth of S. aureus within A549 Cells 
Previous work has shown that agr expression precedes escape of 
internalised S. aureus from the host endosome (Qazi et al., 2001), 
suggestive of a role for agr regulated gene products in the breaching of 
the host endosome. 
 
 
 
FIGURE 4.21: Cell Invasion Assay 
Bioluminescence as relative light units (RLU) divided by optical density (OD) of S. aureus 
RN6390 harbouring pSB2030 S. aureus RN6390 harbouring pSB2035. For comparison, 
different scales are used to represent data relating to growth (left y axis) and agr 
expression (right y axis) to compensate for variations in promoter strength. Results 
represent the mean value of 6 data points for each reading. 
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Preliminary experimentation confirmed that agr is activated before 
replication of internalised S. aureus occurs (Figure 4.21). Invasion assays 
were carried out with both the existing agr reporter strain S. aureus 
RN6390 pSB2035 and the growth reporter strain S. aureus RN6390 
pSB2030. Bioluminescence from S. aureus RN6390 pSB2035 peaked at 
9.5 hours, whereas bioluminescence from S. aureus RN6390 pSB2030 
was not at a maximum until approximately 15 hours, indicative of 
endosomal lysis due to production of agr controlled gene products, and 
consequent bacterial replication within the host cell cytoplasm. 
 
In order to determine the involvement of agr regulated gene products, 
specifically haemolysins, in endosomal escape, this study aimed to use 
the haemolysin mutants in an in vitro invasion assay, with the intention of 
using the findings in conjunction with the MRI reporter system to design a 
specific disease model. Again, while the β-haemolysin mutant was under 
construction, initial experiments were carried out using the S. aureus 
RN6390 ∆hla mutant. S. aureus RN6390 and S. aureus RN6390 ∆hla 
were transduced with an expression vector, pMK4 PxylA-gfp-term, which 
incorporated the PxylA and the gfp gene. This plasmid was chosen for 
preliminary experiments due to its low metabolic demand in contrast with 
lux containing vectors. 
 
Results indicate that the ∆hla is less able to replicate when internalised 
within A549 cells than the wildtype (Figure 4.22). 
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FIGURE 4.22: Cell Invasion Assay 
Fluorescence normalised for growth of S. aureus RN6390 and S. aureus RN6390 ∆hla, 
both harbouring pMK4 PxylA-gfp-term Results represent the mean value of 3 data points 
for each reading.  
 
 
Unfortunately, during this work, Jarry et al. (2008) documented a major 
role for α-haemolysin in endosomal escape. Due to this fact, coupled with 
the time restrictions of the study, further work with the other haemolysin 
mutants, including the newly constructed β-haemolysin mutant, was halted 
in favour of other aspects of the project. 
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5.0: IN V IVO EV ALUATION OF AN S. AUREUS MRI  
REPORTER IN MICE 
 
5.1: Objectives 
 
One of the main aims of this study was to develop an imaging modality 
which enables the non-invasive in vivo detection of bacterial reporter gene 
expression while offering detailed anatomical information. To accomplish 
this, an MRI bacterioferritin reporter gene for S. aureus was constructed 
and evaluated in vitro as described in Chapter 3. The next step was to use 
this system in pilot studies in vivo to confirm its potential for studying 
specific aspects of staphylococcal disease. 
 
5.2: Introduction 
 
Mice have been successfully used in bioluminescence optical imaging due 
to their relatively small size and therefore reduced light attenuation by 
tissue layers. The MRI reporter genes in this study were constructed with a 
downstream lux cassette for in vitro evaluation, making the mouse model 
ideal for the in vivo evaluation of the reporter system, since the 
bioluminescence can be utilised as a preliminary test of reporter gene 
function. Previous work with BFR MRI reporter genes in E. coli 
demonstrated the effective use of mouse thigh tumour models (Hill et al., 
manuscript in preparation). E. coli was shown to colonise the tumours in 
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high numbers allowing for a more dramatic contrast during MRI. In fact, a 
range of bacteria showing preferential accumulation in tumours have been 
studied (Kimura et al., 1980; Riedel et al., 2007; Stritzker et al., 2007; 
Brader et al., 2008). Specific colonisation of this nature by S. aureus would 
enable the relatively easy removal of the colonisation site for further in 
vitro analysis, making the mouse thigh tumour model an ideal candidate 
for experimental use in this study. 
 
 
5.3: Results 
 
5.3.1: Preliminary in vivo Evaluation of MRI Reporter Function 
In order to determine functionality of the expression vectors in vivo, three 
groups of mice were inoculated in the tail vein with 1 x 109 S. aureus 
RN6390 harbouring either the MRI reporter plasmids, pUNK1 PS10-bfr-
luxterm and pUNK1 P3-bfr-luxterm, or a control plasmid, pUNK1 PS10-dual-
term, which is approximately the same size as the MRI reporter plasmids. 
Each test group contained three mice which were monitored over a 3 day 
period using a Berthold NightOWL to visualise luminescence. 
 
Colonisation of the initial inoculation site in the tail by S. aureus pUNK 
PS10-dual-term can be seen after 1 day, with further colonisation of the 
tumours and also localisation in thoracic organs in the following 2 days 
(Figure 5.1). This indicates that the reporter gene in the recombinant S. 
aureus are expressed in vivo, and are maintained for at least 3 days. 
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FIGURE 5.1: Photos overlaid with luminescence images of mice inoculated with S. 
aureus harbouring pUNK1 PS10-dual-term. Images show luminescence 1, 2 and 3 days 
post-inoculation. Order of mice does not remain the same for each picture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5.2: Photos overlaid with luminescence images of mice inoculated with S. 
aureus harbouring pUNK1 PS10-bfr-luxterm. Images show luminescence 2 and 3 days 
post-inoculation. Order of mice does not remain the same for each picture. 
 
DAY 2 DAY 3
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FIGURE 5.3: Photos overlaid with luminescence images of mice inoculated with S. 
aureus harbouring pUNK1 P3-bfr-luxterm. Images show luminescence 1 day post-
inoculation. 
 
 
No bioluminescence was observed in mice inoculated with S. aureus 
pUNK1 PS10-bfr-luxterm on day 1 (Figure 5.2). However, on days 2 and 3 
the pattern of colonisation was similar to that of S. aureus pUNK1 PS10-
dual-term. Mice inoculated with S. aureus pUNK1 P3-bfr-luxterm showed 
colonisation of the inoculation site in the tail after 1 day (Figure 5.3). 
Interestingly, no bioluminescence was observed on days 2 and 3. Despite 
this, bioluminescence detected at the inoculation site 1 day post-
inoculation clearly demonstrates that like the other two plasmids, pUNK1 
P3-bfr-luxterm is also expressed in vivo. The lack of bioluminescence 2 
and 3 days post-inoculation could be due to plasmid loss. However, the 
maintenance of plasmid in the other two test groups makes this unlikely, 
especially due to the fact that all expression vectors are approximately the 
same size. A more feasible cause is the nature of the P3 promoter which, 
unlike the PS10 promoter, is not expressed constitutively, but rather in 
DAY 1
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relation to increased bacterial cell numbers, meaning that at the time the 
mice were imaged, the promoter may not have been expressed. 
 
These images confirm expression of the reporters, suggesting that 
bacterioferritin should be successfully synthesised in vivo. MR imaging of 
the colonised tumours should therefore demonstrate contrast as a 
darkening of T2-weighted images generated by the loading of iron onto the 
endogenous bacterioferritin. 
 
Unfortunately, due to time restrictions, the mice used in the pilot study 
were not scanned using the MRI scanner. Consequently, the S. aureus 
haemolysin mutants could not be evaluated in conjunction with the MRI 
reporter system in vivo as the reporter genes first need to be fully 
evaluated prior to use in the animal model. 
 
5.3.2: Evaluation of Colonisation 
 
5.3.2.1: Viable Cell Counts 
In order to confirm colonisation of the tumours with S. aureus, and to 
additionally determine localisation of other thoracic organs, the tumours, 
spleens and livers of one mouse from each of the three groups inoculated 
with either S. aureus pUNK1 PS10-dual-term, S. aureus pUNK1 PS10-bfr-
luxterm or S. aureus pUNK1 P3-bfr-luxterm were removed and weighed 
before being homogenised with 1ml PBS and plated at varying dilutions 
both with antibiotic selection (5µg ml-1 Erm) and without  antibiotic 
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selection (LB) (Figure 5.4). Plates with between 10 and 300 colonies were 
included in the data. CFU g-1 were then calculated for each tissue. 
 
 
 
FIGURE 5.4: Viable cell counts from the livers, spleens and tumours of one mouse from 
each test group. Mice were inoculated with S. aureus pUNK1 PS10-dual-term (1 on the 
graph), S. aureus pUNK1 PS10-bfr-luxterm (2 on the graph) or S. aureus pUNK1 P3-bfr-
luxterm (3 on the graph).  
 
 
Viable cell counts from the tumours support the suggestion in response to 
Figures 5.1 and 5.2, that the tumours are colonised by S. aureus. Although 
bioluminescence was not imaged 2 and 3 days post-inoculation in mice 
infected with S. aureus pUNK1 P3-bfr-luxterm, the viable cell counts 
suggest that the tumours were colonised, giving strength to the theory that 
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perhaps lack of light was due to the nature of the promoter, which is not 
constitutively expressed. Both the tumours and livers of all 3 mice 
inoculated with S. aureus pUNK1 PS10-dual-term contained bacteria, with 
no localisation in the spleens either with or without selection. Antibiotic 
selection to determine plasmid loss from recovered bacteria indicates that 
the plasmid is not very stable in the absence of antibiotics in the mice, with 
an average plasmid loss in the livers of 88% and the tumours of 92%. 
Despite this, Figures 5.1 and 5.2 show that plasmid loss has not reduced 
the signal from the expressed lux cassette to levels which are 
undetectable. For use in MRI, selection could be maintained in the mice to 
ensure maximum production of BFR. Another option would be to 
incorporate the plasmid into the S. aureus genome. 
 
 
5.3.2.2: Histological Evaluation of Colonisation 
This work was done in conjunction with Dr. Jochen Stritzker from the 
University of Würzburg in Germany. Histology was carried out on one of 
the removed tumours from a mouse in the test group inoculated with S. 
aureus pUNK1 PS10-bfr-luxterm to determine the region of colonisation. As 
can be seen in Figure 5.5, S. aureus appears to colonise the necrotic 
region of the tumour, as is the case with E. coli (Hill et al., manuscript in 
preparation). However, the distribution of S. aureus within the tumour 
differs to that of E. coli, which forms a ring around the necrotic area. S. 
aureus appears to colonise in a patchy fashion, being much more widely 
distributed throughout the necrotic region. 
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FIGURE 5.5: Confocal microscopy showing colonisation of a tumour removed from a 
mouse inoculated with S. aureus pUNK1 PS10-bfr-luxterm. Actin was stained red to 
visualise tumours and S. aureus was labelled using FITC (A2, B2, C2 and D2). Images 
were then overlaid (A1, B1, C1 and D1). Labelled S. aureus can be seen with (A2) and 
without (B2) background correction. C1 shows the same tumour as in A1 and B1, but 
without anti-Protein A antibody. D1 shows a tumour from a mouse with no S. aureus 
inoculation.  
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6.0: DISCUSSION 
 
6.1: Construction and in vitro Evaluation of an MRI Reporter in S. 
aureus 
The development of MRI reporters for use in the non-invasive in vivo 
studies of bacterial infection, colonisation and transcription would be an 
invaluable tool in the future understanding of bacterial pathogenesis and 
host-microbe interactions during disease processes. The functional and 
anatomical data which could be achieved from such an imaging modality, 
coupled with the potential reduction in animal usage has made this an 
exciting area of research, with a range of MRI reporter gene systems 
currently being studied. Of particular interest is the increasing use of 
ferritins and ferritin-like proteins, which are ideal for use as MRI reporters 
due to their ferroxidase activity which converts stored iron from the Fe2+ 
form to the paramagnetic Fe3+ form, which is responsible for the T2 
contrast modification in MRI (Harrison et al., 1996). Previous studies have 
successfully used human ferritins as MRI reporters in eukaryotic cells 
(Cohen et al., 2005; Genove et al., 2005; Cohen et al., 2007). However, 
despite knowledge of the iron storage properties of bacterial ferritin-like 
proteins, there is no documented evidence of their use as MRI reporters. 
Recently, a range of bacterial ferritin-like genes were evaluated for their 
use as MRI reporters in prokaryotic studies (Hill et al., manuscript in 
preparation). The use of a murine thigh tumour model demonstrated both 
the success of the tumour model for imaging purposes due to bacterial 
tumour targeting, and also the functionality of bacterial ferritin-like proteins 
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as MRI reporters. This study implemented these findings in the 
development of an MRI reporter system for the tracking of S. aureus 
disease processes. 
 
Expression vectors were constructed using both constitutive and inducible 
promoters upstream of the E. coli bfr gene. A luxABCDE cassette was also 
cloned downstream of the bfr for use in the in vitro and preliminary in vivo 
evaluation of the MRI reporter system. The constructs were evaluated in 
vitro and the best were taken forward for use in in vivo studies, namely the 
SaPS10 and P3 constructs. Initial ICP-MS data suggested, however, that 
although it was apparent that BFR was successfully expressed in the 
transformed S. aureus, it did not affect the iron concentrations found in cell 
cultures, suggesting that the BFR was not functional. In its native 
background strain, E. coli, bfr is co-transcribed with the bfd gene, whose 
product, a [2Fe-2S] protein, forms a complex with BFR. Garg et al., (1996) 
suggested a role for this protein in the iron storage function of BFR. This 
would explain the lack of iron collection seen in this study in S. aureus, 
which does not have a bfd gene within its genome. 
 
To test this hypothesis, new expression vectors were constructed 
containing the bfd gene upstream of the bfr gene. SDS-PAGE gels 
showed that E. coli harbouring the bfd/bfr construct appeared to express 
higher levels of BFR. One explanation for this could be translational 
enhancement of the downstream bfr gene due to presence of the bfd 
gene. Iron assays indicated that, as expected, the E. coli harbouring the 
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control plasmid still collected iron due to its native bfr gene and also other 
ferritin-like proteins including FtnA and FtnB (Chiancone et al., 2004). The 
E. coli harbouring the bfr and bfd/bfr constructs both showed increased 
iron collection of a roughly equal scale, which supports previous 
documentation of the role of BFR as an iron storage protein (Bauminger et 
al., 1980; Yariv et al., 1981). This finding is also in line with those of Hill et 
al. (manuscript in preparation), that overexpression of the BFR protein in 
E. coli results in increased iron content of the bacteria. If the bfd gene 
product played a role in the functionality of the BFR then a higher level of 
iron collection would be expected in the E. coli bfd/bfr strain. However, this 
data can not confirm this role for bfd since the SDS-PAGE gels clearly 
showed an increased amount of BFR in this strain, which would also 
contribute to increased iron levels. Additionally, it is difficult to determine 
the effect of bfd in E. coli due to the native bfd expressed in E. coli 
harbouring the bfr construct. To address this issue a ∆bfd E. coli strain 
could be made. 
 
For S. aureus, SDS-PAGE gels revealed that, unlike the BFR expression 
vectors which led to synthesis of BFR, S. aureus harbouring the new 
constructs containing the bfd gene did not express levels of BFR visible by 
SDS-PAGE analysis. This led to the consideration that the presence of the 
bfd gene was somehow affecting the transcription or translation of the bfr 
gene in S. aureus. 
 
  123
The presence of the bfd gene, regardless of a role in BFR functionality, 
was not expected to affect the amount of BFR expressed. A role in BFR 
functionality would only cause an increase in the amount of iron the BFR is 
able to load. Due to the fact that the bfd construct is causing a reduction in 
the amount of BFR synthesised, then any reduction seen in iron loading 
can not be attributed to the role of bfd in iron loading, but rather to the 
reduction in BFR expression. 
 
Iron assays were carried out on these samples to correlate the amount of 
BFR produced to iron loading. Despite the initial ICP-MS data which 
suggested the BFR expressed in S. aureus was not functional, iron assays 
and ICP-MS data carried out on the new constructs showed iron collection 
in both the bfr and bfd/bfr constructs in S. aureus. As would be expected 
from the increased levels of BFR seen in the S. aureus harbouring the bfr 
constructs, this strain also showed the most iron collection. As described 
above, this can not rule out a role for bfd in iron loading due to the fact that 
there is more BFR present in the bfr construct samples. However, despite 
the low levels of BFR in the bfd/bfr construct, these data show that an 
increase in expression of BFR in S. aureus causes increased iron 
collection. Regardless of the mechanism behind this, and any possible 
role for bfd, this indicates that the BFR expression vectors are usable as a 
contrast agent for MRI imaging of S. aureus disease processes. 
 
To determine if the incorporation of the bfd gene was affecting the 
transcription or translation of the bfr gene, bioluminescence assays were 
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carried out with both the bfr and bfd/bfr constructs. One finding from these 
bioluminescence assays was that, compared with the pUNK1 P3-dual-term 
and pUNK1 PS10-dual-term constructs, bioluminescence levels measured 
from the the bfr constructs were over 3 fold less. An explanation for this 
could be that the expression of iron storage proteins in S. aureus has 
somehow affected iron homeostasis within the bacteria. Ferritins within the 
S. aureus cytoplasm could cause low iron concentrations which could 
result in the upregulation of other iron synthesis or scavenging systems. If 
this is the case, the extra metabolic demand placed on the bacteria may 
decrease expression of the MRI reporter genes. Alternatively, the bfr gene 
could be affecting the translation of the lux operon. Another explanation 
could be that the bfr gene is reducing the half life of the mRNA from 
transcription of the operon, resulting in less opportunity for translation to 
occur. This could be investigated further by Northern Blot analysis.  
 
With respect to the potential effects of the bfd gene on the transcription or 
translation of the bfr gene, if the bfd gene was terminating transcription of 
the expression vector, then no bioluminescence signal would be detected 
due to the failure of transcription of the lux cassette. However, if the bfd 
gene was affecting the translation of the bfr gene then light output would 
be maintained since the genes of the lux operon each has its own RBS. 
The bioluminescence assay results showed that the light output from both 
the bfr and bfd/bfr constructs was maintained, suggesting that the 
translation of the bfr gene was being interrupted by the presence of the bfd 
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gene. One cause for this could be the formation of stem loop structures 
within the mRNA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6.1: Diagram showing a potential stem loop in the mRNA sequence of the 
intergenic region between the bfd and bfr genes. The red highlights the RBS of the bfr 
gene and the blue highlights the end of the bfd gene. 
 
 
If a stem loop such as the one depicted in Figure 6.1 formed between the 
3’ end of the bfd gene, the 5’ end of the bfr gene and the intergenic region 
between the genes, this could potentially cause the decrease in translation 
of the bfr gene seen in S. aureus due to inaccessibility of ribosomes to the 
bfr RBS. It is possible that in E. coli the formation of an intergenic stem 
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loop has little effect on translation of the bfr gene due to a strong bfd RBS, 
whereby attached ribosomes can remove the stem loop during translation, 
effectively translationally coupling bfd and bfr. However, the bfd RBS may 
be relatively poor in S. aureus. The ensuing low levels of translation of the 
bfd gene may therefore not be sufficient to remove the stem loop thus 
leaving the bfr RBS occluded. 
 
There are various ways in which this issue could be addressed. One 
option would be to change the codon usage within this region of DNA to 
prevent the formation of stem loops in S. aureus. Alternatively, the bfd 
gene could be incorporated in a separate transcriptional unit, or even in a 
separate vector. However, to justify such changes, an important role for 
bfd would firstly need to be established. Although this route of study is 
extremely interesting, with potential improvements to the MRI reporter 
system should a role for bfd in BFR functionality be discovered, the bfd/bfr 
constructs were developed to address the problem of non-functional BFR 
in response to the initial ICP-MS data. Since repetition of this investigation 
with additional iron assays appears to indicate that the BFR expressed by 
S. aureus harbouring the bfr construct does in fact collect iron, the bfd/bfr 
construct at this stage does not need to be further evaluated until the bfr 
construct is established as a successful MRI reporter. To this end, the bfr 
construct needs to be made more stable. Experiments analysing plasmid 
loss indicated the need for selection to be maintained during in vivo 
experiments to ensure maximum production of BFR. However, introduction 
of the expression vector into the chromosome of the S. aureus would allow 
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for use of the MRI reporter system in different animal models without the 
need for unnecessary invasive procedures to administer the antibiotics. 
 
6.2: Construction and Characterisation of a hlb Mutant and 
Characterisation of Existing Haemolysin Mutants in S. aureus 
Internalised S. aureus enclosed within a host membrane-bound endosome 
has been shown to have the ability to escape this endosome, residing and 
potentially replicating in the host cell cytoplasm (Bayles et al., 1998; 
Wesson et al., 1998). However, at the commencement of the current 
study, the mechanisms via which this escape occurred were not well 
understood. Wesson et al. (1998) suggested a model describing a role for 
agr-regulated quorum sensing in S. aureus internalisation and endosomal 
escape, yet it is not fully clear which genes specifically are important. This 
study aimed to investigate the role of haemolysins, products of genes 
under the control of the agr system which disrupt eukaryotic cell 
membranes, in endosomal escape of internalised S. aureus, and as such, 
several S. aureus haemolysin mutants were characterised and a S. aureus 
hlb mutant was constructed. 
 
PCR indicated that the bacterial mutagenesis of S. aureus using pTS1-
Dest hlb constructed using Gateway® technology was successful. 
Additionally, it would appear that excision of the erm marker was also 
achieved using the pTS1 intC expression vector. This technology was 
developed by Qazi et al. (manuscript in preparation), to enable the 
construction of mutants without the bioburden of resistance gene 
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expression, and also the production of double or triple mutants without the 
need for multiple resistance genes. This is achieved by using allelic 
replacement cassettes during the mutagenesis process in which 
resistance genes are flanked with Streptomyces lividans φC31 attB and 
attP sites. Excision of the resistance gene can then be achieved by 
expression of site-specific recombinase, φC31 integrase (IntC), in the S. 
aureus mutants. The successful use of this technology in this study 
supports the development of this technology by Qazi et al. (manuscript in 
preparation). However, Western blots would need to be carried out for 
formal confirmation of a β-haemolysin negative phenotype.  
 
In addition to the construction of a new S. aureus ∆hlb strain, an existing 
S. aureus RN6390 mutant in α-haemolysin was transduced back into the 
RN6390 background strain in an attempt to overcome problems with the 
transformation of this strain. An S. aureus 8325-4 γ-haemolysin mutant 
was obtained from Tim Foster’s laboratory in Dublin and the mutation was 
also transduced into the RN6390 background strain. Phenotypic analysis 
of the newly transduced strains revealed that the two transduced putative 
S. aureus ∆hla strains were significantly less haemolytic than S. aureus 
RN6390 in rabbit blood. However, the two transduced putative S. aureus 
∆hlg demonstrated no haemolytic activity, indicating that they were not 
expressing α-haemolysin which is specifically active against rabbit 
erythrocytes. Further experiments revealed that the growth phase of the 
bacteria was not the cause of this apparent lack of α-haemolysin 
production, indicating that other mutations within the genome of this strain 
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may be present. This requires further attention by way of PCR, SDS-
PAGE protein gels, Western blots and Southern blots before this strain 
can be used. 
 
Preliminary work using a cell invasion assay and S. aureus harbouring 
growth and agr expression reporter plasmids, confirmed that agr is 
activated before replication of internalised S. aureus occurs. This supports 
work carried out previously by Qazi et al. (2001) and Shompole et al. 
(2003) indicating the occurrence of endosomal lysis due to production of 
agr controlled gene products, before bacterial replication within the host 
cell cytoplasm. However, to ensure that the increase in bioluminescence 
seen with the agr expression reporter plasmid was, in fact, due to 
expression of the agr operon and not because of bacterial replication, a 
microscopic study would have to be done. In the case of this study, 
however, this preliminary work served the purpose of establishing a 
functional assay, and the fact that the data matches that of the previous 
work carried out by Qazi et al. (2001) indicates that the bacteria are 
behaving in a similar way. 
 
A further invasion assay using the S. aureus ∆hla strain indicated a role for 
α-haemolysin in endosomal escape, since the S. aureus ∆hla showed 
reduced growth levels as compared with the S. aureus RN6390 wildtype 
strain. Unfortunately, during this work, Jarry et al. (2008) documented a 
major role for α-haemolysin in endosomal escape. Due to this fact, 
coupled with the time restrictions of the study, the other mutants, including 
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the newly constructed β-haemolysin mutant, were not used in the cell 
invasion assay. However, the haemolysin mutants could hopefully be used 
in conjunction with the MRI reporter gene system in in vivo experiments to 
determine patterns of colonisation during infection within the mutants. 
 
6.3: In vivo Evaluation of an S. aureus MRI Reporter in Mice 
Preliminary in vivo experiments tracking bioluminescence demonstrated 
expression of the MRI reporter genes, suggesting that bacterioferritin 
should be successfully synthesised in vivo. MR imaging of the colonised 
tumours should therefore demonstrate contrast generated by the loading 
of iron onto the endogenous bacterioferritin. Bioluminescence was only 
detected from the S. aureus pUNK1 P3-bfr-luxterm strain, however, on day 
1, with light only being emittied from the inoculation site. It was thought 
that this could be due to the temporal nature of the expression of the P3 
promoter which, unlike the PS10 promoter, is not expressed constitutively, 
but rather in relation to bacterial cell numbers. This would be in line with 
observations made by Wright et al. (2005), who noted that a P3-lux 
construct in S. aureus used in vivo in a mouse model demonstrated 
periods of expression and subsequent bioluminescence, followed by 
periods of reduced bioluminescence. This was attributed to the entry of the 
bacteria into stationary phase. Some 48-72 hours later, bioluminescence 
signals were recorded again, which were explained as a result of renewed 
bacterial growth. 
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Evaluation of the stability of the MRI reporter gene in vivo indicated that 
although plasmid loss occurred to quite a high level, it was obviously not 
significant enough to reduce the bioluminescence output to undetectable 
levels. However, for use in MRI, plasmid stability is vital to ensure maximal 
synthesis of BFR for optimal contrast. 
 
As seen with other bacterial species including E. coli, Listeria 
monocytogenes and Salmonella species, S. aureus preferentially 
colonised the tumour, with bacteria also found in the liver (Riedel et al., 
2007; Stritzker et al., 2007; Brader et al., 2008). The presence of bacteria 
in the liver could be due to failure of bacterial clearance by the liver. 
Colonisation of mice livers and spleens by a variety of pathogenic tumour 
targeting bacteria was observed by Stritzker et al. (2007), but reduction of 
bacterial load of E. coli Nissle 1917 in the spleen was achieved at lower 
bacterial loading levels. Different loading levels of S. aureus could 
therefore be trialed to determine an innoculum load which can achieve 
tumour colonisation without excessive liver colonisation.  
 
Due to the relatively low levels of iron present in S. aureus samples as 
determined by ICP-MS, the tumours in this study were not scanned by 
MRI due to cost implications. However, colonisation of tumours by S. 
aureus seen in this study makes the mouse thigh tumour model ideal for 
development of this MRI reporter system since a specific area can be 
imaged using MRI, and parameters changed with relative reproducibility of 
the colonisation pattern in order to determine optimal conditions to achieve 
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MRI contrast. Once the MRI reporter system has be optimised for iron 
collection in S. aureus, MR imaging can be carried out to confirm the 
efficacy of this MRI reporter system for use in the monitoring of S. aureus 
disease processes. 
 
Histology of one of the tumours from a mouse inoculated with S. aureus 
pUNK1 PS10-bfr-luxterm revealed interesting information regarding the 
colonisation pattern of S. aureus within the tumour. This type of ex vivo 
technique is currently required for such detailed anatomical information to 
be gained. However, development of the MRI reporter system would 
abolish such a necessity, providing such information without the need for 
experimental animals to be sacrificed. 
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